Institutes
Refine
Year of publication
- 2022 (386) (remove)
Document Type
- Article (329)
- Preprint (24)
- Conference Proceeding (19)
- Doctoral Thesis (14)
Language
- English (386) (remove)
Has Fulltext
- yes (386)
Is part of the Bibliography
- no (386)
Keywords
- inflammation (8)
- COVID-19 (7)
- Inflammation (6)
- Cancer (5)
- bladder cancer (5)
- data science (5)
- glioblastoma (5)
- prostate cancer (5)
- ADHD (4)
- Radiotherapy (4)
- SARS-CoV-2 (4)
- Surgery (4)
- cancer (4)
- glioma (4)
- hepatocellular carcinoma (4)
- Biomarker (3)
- Lung failure (3)
- NSCLC (3)
- artificial intelligence (3)
- digital medicine (3)
- immunotherapy (3)
- machine learning (3)
- machine-learning (3)
- periodontitis (3)
- polypharmacy (3)
- radical prostatectomy (3)
- stroke (3)
- ACLF (2)
- Accidental reaction (2)
- Allergen avoidance (2)
- Anti-IgE (2)
- Attention-deficit/hyperactivity disorder (2)
- Biomedical informatics (2)
- COVID-19 surveillance (2)
- Cochlear implant (2)
- Data science (2)
- Depression (2)
- Elderly (2)
- Emotion regulation (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epigenetics (2)
- Geriatric patients (2)
- Germany (2)
- Immunology (2)
- LncRNA (2)
- MRI (2)
- Magnetic resonance imaging (2)
- Medical research (2)
- NADPH oxidase (2)
- NS5A (2)
- Omicron (2)
- Oncology (2)
- Oral immunotherapy (2)
- Penile carcinomas (2)
- Prostate cancer (2)
- RNAseq (2)
- Rectal cancer (2)
- Rheumatoid arthritis (2)
- SARS-CoV-2 monitoring (2)
- SPM (2)
- Sex (2)
- T-cell (2)
- TAVI (2)
- TIPS (2)
- Tight junctions (2)
- Translational research (2)
- Uteroglobin (2)
- antiseizure medication (2)
- aortic stenosis (2)
- autophagy (2)
- biliary stricture (2)
- brain metastases (2)
- brain metastasis (2)
- cartilage (2)
- chemotherapy (2)
- child (2)
- cognition (2)
- complication (2)
- coronavirus (2)
- depression (2)
- diagnosis (2)
- elderly (2)
- ephrinB2 (2)
- epilepsy (2)
- functional outcome (2)
- general practice (2)
- glycolysis (2)
- growth (2)
- hyperglycemia (2)
- hypoxia (2)
- immune checkpoint inhibitors (2)
- immunity (2)
- immunohistochemistry (2)
- infection (2)
- integrins (2)
- invasion (2)
- leptin (2)
- lipoxygenase (2)
- long non-coding RNA (2)
- lung cancer (2)
- macrophage (2)
- microRNA (2)
- microglia (2)
- motility (2)
- multidetector computed tomography (2)
- multimorbidity (2)
- neurodegeneration (2)
- neuropathic pain (2)
- nivolumab (2)
- nociception (2)
- osteoarthritis (2)
- outcomes (2)
- pain (2)
- pandemic (2)
- patients (2)
- pediatric surgery (2)
- process evaluation (2)
- proteomics (2)
- quality of life (2)
- radical cystectomy (2)
- resolution of inflammation (2)
- scaffold (2)
- sphingolipids (2)
- stereotactic radiosurgery (2)
- systematic review (2)
- temozolomide (2)
- thrombolysis (2)
- transcription factor (2)
- traumatic brain injury (2)
- tumor microenvironment (2)
- vaccination (2)
- 177Lu-PSMA-617 (1)
- 223Radium-dichloride (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3D culture (1)
- 3D laparoscopy (1)
- 3D-models (1)
- 3D-printing (1)
- A498 cells (1)
- ABC transporter (1)
- ACKR (1)
- ADHS (1)
- AKT-mTOR pathway (1)
- AML (1)
- ARDS (1)
- ATM (1)
- Ablation Techniques (1)
- Acinetobacter baumannii (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute (1)
- Acute decompensation (1)
- Acute kidney injury (1)
- Acute myeloid leukaemia (1)
- Acute-on-chronic liver failure (1)
- Affect (1)
- Aggression (1)
- Aging (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Ambulatory Assessment (1)
- Anaemia (1)
- Anakinra (1)
- Angiogenesis (1)
- Angiography (1)
- Animal models (1)
- Antibiotics (1)
- Antibodies (1)
- Antigen test (1)
- Aortic stenosis (1)
- Aperiodic (1)
- Apoptosis (1)
- Arteria ophthalmica (1)
- Aspergillus (1)
- Ataxia (1)
- Atrial fibrillation classification (1)
- Attentional bias (1)
- Auditory system (1)
- Autoimmunity (1)
- Autophagy (1)
- Autopsy (1)
- Ayahuasca (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BET proteins (1)
- BH3 mimetics (1)
- BMNC (1)
- BMP4 (1)
- BNT162b2 (1)
- Bacillus subtilis (1)
- Bacteraemia (1)
- Bacteria (1)
- Balance (1)
- Bartonella adhesin A (1)
- Behavioral tests (1)
- Bentall operation (1)
- Biceps brachii (1)
- Bilateral sagittal split osteotomy (1)
- Biological sciences (1)
- Bipolar disorder (1)
- Blindness (1)
- Blood loss (1)
- Blood pressure (1)
- Blood sample handling (1)
- Bloodstream infections (1)
- Body modification (1)
- Bone conduction devices (1)
- Bone dust (1)
- Bone marrow aspiration (1)
- Brachytherapy (1)
- Brain (1)
- Brodalumab (1)
- Burkholderia arboris (1)
- C-reactive protein (1)
- CAR (1)
- CBC (1)
- CD4+ T cells (1)
- CD40 (1)
- CDK-cyclin axis (1)
- CHEPs (1)
- CHRDL1 (1)
- CK2α (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CNS tumor (1)
- COMP (1)
- COVID-19 epitope signatures (1)
- CQL (1)
- CRP (1)
- CRT (1)
- CT (1)
- CTGF (1)
- CXCL13 (1)
- CaMPARI (1)
- Calliphoridae (1)
- Capsaicin (1)
- Cardiac infarction (1)
- Cardiac remodeling (1)
- Cardiovascular diseases (1)
- Case report (1)
- Catheters (1)
- Cell Biology (1)
- Cell death (1)
- Cell death and immune response (1)
- Cellular network formation (1)
- Central Europe (1)
- Cerebellum (1)
- Cerebral oxygen saturation (1)
- ChAdOx1-S (1)
- Chemoradiotherapy (1)
- Chemotherapy (1)
- Chronic lymphocytic leukemia (1)
- Circulating MiRNA (1)
- Cirrhosis (1)
- Classification (1)
- Click chemistry (1)
- Clinical Trials and Observations (1)
- Clinical management (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical trials (1)
- Cognition (1)
- Cognitive (1)
- Colloids (1)
- Colony stimulating factor 1 receptor (1)
- Comorbidities (1)
- Comorbidity (1)
- Comparative analysis (1)
- Complete response (1)
- Completed suicide (1)
- Complex elbow fractures (1)
- Comprehensive complication index (1)
- Computer software (1)
- Concurrent CNS diseases (1)
- Congenital (1)
- Connective tissue (1)
- Consensus statement (1)
- Conventional and unconventional ubiquitination (1)
- Convolutional Neural Networks (1)
- Coronavirus (1)
- Coronaviruses (1)
- Culex pipiens biotypes pipiens/molestus (1)
- CysLTR1 (1)
- D-amino acid oxidase (1)
- DAA (1)
- DNA methylation (1)
- DNA mismatch repair (1)
- DNA-PK (1)
- DNA-based identification (1)
- DVI (1)
- DWI (1)
- Data preprocessing (1)
- Data structure detection (1)
- Deep brain stimulation (1)
- Deep neural network (1)
- Degradation (1)
- Dental students (1)
- Depression stigma (1)
- Detection workflow (1)
- Dexterity (1)
- Diagnostic imaging (1)
- Diagnostic tests (1)
- Diet (1)
- Dimethyltryptamine (1)
- Donor screening (1)
- Dot-probe task (1)
- Downgrading (1)
- Dynamic MRI (1)
- EEG (1)
- EGFR (1)
- ER stress (1)
- Elderly trauma patient (1)
- Emotional intelligence (1)
- Empathy (1)
- Endocannabinoids (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endorectal (1)
- Endothelial (1)
- Endothelial-to-mesenchymal transition (1)
- Energy-efficiency (1)
- Environmental impacts (1)
- Epidemiology (1)
- Epilepsy (1)
- Erythrophagocytosis (1)
- Europe (1)
- Euthymic phase (1)
- Explicit (1)
- Extracorporeal devices (1)
- FDG-PET/CT (1)
- FFLU (1)
- FHIR (1)
- FHIR Search (1)
- FPR (1)
- Face masks (1)
- Fall (1)
- Famines (1)
- Fast Healthcare Interoperability Resources (1)
- Feasibility (1)
- Fetal heart (1)
- Fibroblast (1)
- Filgrastim (1)
- Filler (1)
- Flavin mononucleotide (1)
- Follicular lymphoma (1)
- Follow-ups (1)
- Fondaparinux (1)
- Fracture models (1)
- Frameshift (1)
- Fruit fly (1)
- Functional electrical stimulation (1)
- Functional outcomes (1)
- Funktionelle Bildgebung (1)
- G3BP1 (1)
- GDF11 (1)
- GEMs (1)
- GPCR (1)
- GRAND-SLAM (1)
- GSH (1)
- Gene (1)
- Gene expression (1)
- Gene sequencing (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetics (1)
- Genetics research (1)
- Geschlecht (1)
- Glabella (1)
- Gleason Grade group (1)
- Glioblastoma (1)
- Gradient boosting (1)
- Groin pain (1)
- Gut bacteria (1)
- GvL (1)
- HCV (1)
- HEOR (1)
- HES (1)
- HIF (1)
- HIF-1α (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIPPO signalling (1)
- HL7 FHIR (1)
- HNSCC (1)
- HPV infection (1)
- HSCT (1)
- Haemodialysis (1)
- Hardware erosion (1)
- Head neck cancer (1)
- Health policy (1)
- Health sciences (1)
- Healthcare (1)
- Healthy stem cell donors (1)
- Heart (1)
- Heart defects (1)
- Heart rate (1)
- Hematoma (1)
- Hematopoietic stem cell transplant (1)
- Hemosiderin (1)
- Hepatitis C (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatotoxicity (1)
- Heterologous prime-boost (1)
- High oblique sagittal osteotomy (1)
- Hip revision (1)
- HoLEP (1)
- Hodgkin lymphoma (1)
- Holmium laser enucleation (1)
- Home Care Services [MeSH] (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human retroelements (1)
- Human visual cortex (1)
- Hydroxyethyl starch (1)
- Hypertension (1)
- Hypertensive disorders in pregnancy (1)
- IGF-1 (1)
- IL-17 (1)
- IR (1)
- Idelalisib (1)
- Identification (1)
- Identifier (1)
- Immunity (1)
- Immunoassay (1)
- Immunogenicity (1)
- Immunotherapy (1)
- Implicit (1)
- Impoverishment (1)
- Impulse generator (1)
- In-TIPS thrombosis (1)
- Incidental prostate cancer (1)
- Induction therapy (1)
- Inequality (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Integrative Network Analysis (1)
- Interaction (1)
- Interleukin-1 (1)
- Intermediate-risk (1)
- Intraoperative procedure (1)
- Intravenous iron (1)
- Iron deficiency (1)
- Isoforms (1)
- Jaw surgery (1)
- Jurkat (1)
- Kidneys (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knees (1)
- LAMTOR1 (1)
- LASS (1)
- LC-MS-based lipid mediator analysis (1)
- LCD-Array (1)
- Large vessel occlusion (1)
- Lee-type (1)
- Legionella pneumophila (1)
- Legs (1)
- Ligand post-insertion (1)
- Lipid peroxidation (1)
- Liver (1)
- Liver Fibrosis (1)
- Local therapy (1)
- Long interspersed nuclear elements (LINE) (1)
- Long-term follow-up (1)
- Long-term results (1)
- Low-molecular-weight heparin (1)
- MAP kinase (1)
- MEN1 (1)
- MGMT (1)
- MGMT promoter (1)
- MLH1 (1)
- MMPs (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- Machine learning (1)
- Machine-learning (1)
- Maintenance therapy (1)
- Major depressive disorder (1)
- Malignancy (1)
- Malnutrition (1)
- Masquelet technique (1)
- Mathematical biosciences (1)
- Medical Oncology (1)
- Mental disorder (1)
- Metabolism (1)
- Metabolomics (1)
- Metastasis (1)
- Methylation (1)
- MiR-29 (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microbiome (1)
- Microenvironment (1)
- Microglia (1)
- Microplastic (1)
- Mild hypoxia (1)
- Mini-monovision (1)
- Mitochondria (1)
- Mitochondrial complex I (1)
- Mixed hearing loss (1)
- Model organisms (1)
- Molecular autopsy (1)
- Molecular mimicry (1)
- Monocyte gene expression (1)
- Mood (1)
- Morphology (1)
- Mortality (1)
- Motility (1)
- Mouse (1)
- Mouse models (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multiple sclerosis (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle damage (1)
- Muscle pain (1)
- Myeloid Neoplasia (1)
- Myocardial infarction (1)
- Myocarditis (1)
- NASH (1)
- NIS (1)
- NR4A2 (1)
- NR4A3 (1)
- NVBP (1)
- Nanoplastic (1)
- Needs Assessment [MeSH] (1)
- Neurodegenerative syndromes (1)
- Neurodevelopmental disorder (1)
- Neuromuscular exercise (1)
- Neuroscience (1)
- Nkx2-5 (1)
- Non-diffractive EDOF-IOL (1)
- Nonoperative management (1)
- Nox (1)
- Nox inhibition (1)
- Nrf2 (1)
- Obesity (1)
- Observational (1)
- Occlusion (1)
- Older patients (1)
- Omicron variant BA.1 (1)
- One-leg stand (1)
- Online education (1)
- Ophthalmoplegia (1)
- Optical phenomena (1)
- Organ preservation (1)
- Orthognathic surgery (1)
- Orthopaedics (1)
- Oscillating saws (1)
- Outcome (1)
- PBBM (1)
- PCR (1)
- PD-L1 (1)
- PDPK1 (1)
- PI3K (1)
- PI3K inhibitor (1)
- PLGA (1)
- PMI (1)
- PPTC7 (1)
- PRG5 (1)
- PSMA (1)
- PTEN (1)
- PacBio SMRT sequencing (1)
- Paediatric cancer (1)
- Palliative Care [MeSH] (1)
- Pandemic (1)
- Papillon-Lefèvre syndrome (1)
- Parkinson’s disease (1)
- Particle load reduction (1)
- Particle size distribution (1)
- Particle toxicity (1)
- Particulate matter (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient care (1)
- Patient safety (1)
- Perceived stigma (1)
- Periodic (1)
- Peripheral blood smears (1)
- Personal stigma (1)
- Personality inventory (1)
- Phagocytosis (1)
- Physical activity (1)
- Physical and mental health (1)
- Physics (1)
- Placental organoids (1)
- Plasma (1)
- Plastic pollution (1)
- Plasticity (1)
- Plastics (1)
- Polytrauma (1)
- Portuguese population (1)
- Positron emission tomography (1)
- Post-mortem genetic screening (1)
- Postural control (1)
- Postural sway (1)
- Pre-analytics (1)
- Pre-operative radiotherapy (1)
- Precision medicine (1)
- Preclinical research (1)
- Predictive markers (1)
- Predominant polarity (1)
- Preeclampsia (1)
- Presbyopia (1)
- Primary cilium (1)
- Propensity score matching (1)
- Protein (1)
- Protocol (1)
- Pseudomonas aeruginosa (1)
- Psychedelics (1)
- Psychiatric traits (1)
- Purdue Pegboard (1)
- Qualitative Research [MeSH] (1)
- Quality of Health Care [MeSH] (1)
- Quality of life (1)
- Quantitative Imaging (1)
- Quarantine (1)
- RAS (1)
- RCC (1)
- RCT (1)
- RESLES (1)
- RNA (1)
- RNA stability (1)
- RNA therapeutics (1)
- RNA turnover (1)
- RNA virus (1)
- Rab7 (1)
- Radical prostatectomy (1)
- Ragulator complex (1)
- Random forest (1)
- Randomized controlled trials (1)
- Reactogenicity (1)
- Real world study (1)
- Refractive lense exchange (1)
- Registry (1)
- Rehabilitation (1)
- Relapse surveillance (1)
- Research data (1)
- Research patterns (1)
- Research validity (1)
- Resilience (1)
- Reverse electron transfer (1)
- Rhabdomyosarcoma (1)
- Ribosomal RNA (1)
- Risk assessment (1)
- Rodents (1)
- Routinely Collected Health Data [MeSH] (1)
- S1P (1)
- S1P receptors (1)
- S1P5 (1)
- S1PR5 (1)
- SARS coronavirus (1)
- SARS-CoV-2 testing (1)
- SARS-CoV-2-specific T cells (1)
- SARS-CoV2 (1)
- SF-12 (1)
- SLAM-seq (1)
- SMOC1 (1)
- SOD (1)
- SSTI (1)
- STAT3 (1)
- SUDEP (1)
- Safety culture (1)
- Sanger Sequencing (1)
- Sarcophagidae (1)
- Scalp defect (1)
- Scheduling of radiotherapy (1)
- Schizophrenia (1)
- Screening (1)
- Self-renewal (1)
- Sequelae (1)
- Serology (1)
- Serum (1)
- Siderosis (1)
- Single positive core biopsy (1)
- Skeletal muscles (1)
- Sodium chloride (1)
- Soft tissue sarcoma (1)
- Sphk1 (1)
- Sphk2 (1)
- Sports and exercise medicine (1)
- Statin (1)
- Stigma scale (1)
- Stoppa approach (1)
- Stroke (1)
- Stroke unit (1)
- Subjective effects (1)
- Sudden cardiac death (1)
- Sudden death (1)
- Suicide (1)
- Suicide attempt (1)
- Superficial vein thrombosis (1)
- Support vector machine (1)
- Surgical oncology (1)
- Synapse (1)
- Synovial sarcoma (1)
- Systems & Computational Biology (1)
- T helper cell differentiation (1)
- TBI (1)
- TIRADS (1)
- TOR signalling (1)
- TTW nodules (1)
- TUR-P (1)
- Targeted delivery (1)
- Targeted therapies (1)
- Tattoo (1)
- Teaching (1)
- Technical data (1)
- Temozolomide (1)
- Therapy (1)
- Thoracic trauma (1)
- Tissue expander (1)
- Tissue microarray (1)
- Tissue-specificity (1)
- Total elbow arthroplasty (1)
- Toxicity (1)
- Training (1)
- Transfusion (1)
- Transitional fractures 3D printing (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Transurethral resection of the prostate (1)
- Trauma (1)
- Trauma centre (1)
- TraumaRegister DGU® (1)
- Traumatic brain injury (1)
- Traumatology (1)
- Travel regulations (1)
- Treatment (1)
- Treatment management (1)
- Treatment response (1)
- Truncating mutation (1)
- Truncus arteriosus (1)
- Tumor microenvironment (1)
- Tumour immunology (1)
- UGCG (1)
- UPR (1)
- USP28 (1)
- USP32 (1)
- Ultrasound (1)
- Undergraduate (1)
- Upgrading (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Urine (1)
- Urological oncology (1)
- V4 (1)
- VUS (1)
- Vaccination (1)
- Valvular cardiomyopathy (1)
- Variant of concern (1)
- Vasculitis (1)
- Venous thrombosis (1)
- Vibroarthrography (1)
- Viral hepatitis (1)
- Viral infection (1)
- Viral oncology (1)
- Virological testing (1)
- Visual-field localizer (1)
- Volume therapy (1)
- Von Hippel–Landau (1)
- Wastewater-based epidemiology (WBE) (1)
- Zebrafish (1)
- Zuckerkandl’s tubercle (1)
- aGVHD (1)
- acarboxyprothrombin (1)
- acetabular fracture (1)
- acute infections (1)
- acute lymphoblastic leukemia (1)
- acute respiratory distress syndrome (1)
- acute stroke (1)
- acute-on-chronic liver failure (1)
- additive manufacturing (1)
- adipose-derived stromal/stem cells (1)
- adjuvant chemotherapy (1)
- adolescents (1)
- age (1)
- aging (1)
- albumin (1)
- alcohol (1)
- algorithm (1)
- aligners (1)
- alpha-fetoprotein (1)
- alphaSynuclein (1)
- alteplase (1)
- alternative splicing (1)
- alveolar ridge augmentation (1)
- amino acids (1)
- amygdalin (1)
- anaplastic large cell lymphoma (1)
- anemia (1)
- anesthesia (1)
- angiogenesis (1)
- animal model (1)
- anorexia nervosa (1)
- anti-EGFR therapy (1)
- anti-bacterial agents (1)
- anti-inflammatory agent (1)
- antiangiogenic therapy (1)
- antiangiogenic therapy resistance (1)
- antioxidant (1)
- antiviral agents (1)
- apex (1)
- arachidonic acid (1)
- articular chondrocytes (1)
- asparaginyl endopepdidase (AEP) (1)
- atezolizumab (1)
- attachment loss (1)
- attention (1)
- atypical EGFR mutations (1)
- autophagy-dependent cell death (1)
- awake surgery (1)
- benchmarking (1)
- beta2-adrenoceptor (1)
- bevacizumab (1)
- biofilm (1)
- bioimaging (1)
- bioinformatics (1)
- biomarker (1)
- biorelevant dissolution (1)
- biotin deficiency (1)
- bone (1)
- bone marrow microenvironment (1)
- bone metastasis (1)
- bone regeneration (1)
- bone tissue engineering (1)
- bowel management (1)
- breast cancer (1)
- breast tumor (1)
- bromodomain and extraterminal (BET) protein (1)
- bronchial epithelium (1)
- bulimia nervosa (1)
- buparlisib (1)
- burden of illness (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- c-MYC (1)
- cabazitaxel (1)
- cabozantinib (1)
- cardiac remodeling (1)
- cardiovascular system (1)
- caregivers (1)
- casein kinase 2 (1)
- cataract surgery (1)
- cataract surgery workflow (1)
- cellular heterogeneity (1)
- cellular inflammatory response (1)
- ceramide synthase (1)
- cerebral pseudoprogression (1)
- cerebral vasospasm (CVS) (1)
- cerebrovascular disease (1)
- chemoradiotherapy (1)
- chemorefractory metastatic colorectal cancer (1)
- children (1)
- chimeric antigen receptor (CAR) (1)
- chromaffin cell (1)
- chronic hypoxia (1)
- chronic infections (1)
- clear cell renal cell carcinoma (1)
- clear cell sarcoma (1)
- clear lens exchange (1)
- climate change genomics (1)
- clinical decision support (1)
- clinical isolates (1)
- clinical outcome (1)
- clinical study (1)
- clinically relevant dissolution specifications (1)
- clonal transfer (1)
- co-infection (1)
- cognitive impairment (CI) (1)
- colon (1)
- colony formation (1)
- colorectal cancer (1)
- complementary medicine (1)
- complementary/alternative medicine (CAM) (1)
- computational pathology (1)
- confinement (1)
- congenital duodenal obstruction (1)
- consensus classification (1)
- consensus data set (1)
- constipation (1)
- continuity of care (1)
- copper free strain-promoted azide alkyne cycloaddition (SPAAC) (1)
- corpus callosum (1)
- cortex-based alignment (1)
- cortical impact (1)
- corticospinal tracts (1)
- cost analysis (1)
- cost containment (1)
- cost of illness (1)
- counseling (1)
- counselling (1)
- critical care (1)
- critical size defect (1)
- cryopreservation (1)
- cystic fibrosis (1)
- cytochrome c oxidase I (COI) (1)
- cytokine(s) (1)
- cytosolic free calcium (1)
- data analysis (1)
- data management (1)
- de novo transcription (1)
- decision tree (1)
- deep learning (1)
- delay (1)
- delayed cerebral ischemia (DCI) (1)
- dendritic cell (1)
- dental academic degrees (1)
- dental educationcation (1)
- dental implant (1)
- dental implants (1)
- deproteinized bovine bone matrix (DBBM) (1)
- detection task (1)
- deubiquitinase (DUB) (1)
- diabetes (1)
- diagnostic imaging (1)
- differential expression (1)
- diffusion-weighted magnetic resonance imaging (1)
- digital decision-support (1)
- disease outbreaks (1)
- disease vectors (1)
- distributed analysis (1)
- docetaxel (1)
- doctoral degrees (1)
- dopamine (1)
- double negative (1)
- double-pigtail stents (1)
- dysphagia (1)
- eating disorders (1)
- economic burden (1)
- education (1)
- efficiency (1)
- eicosanoid (1)
- electron transfer chain (1)
- electronic diaries (1)
- electrophoresis (1)
- enamel matrix derivatives (1)
- encephalopathy (1)
- endoscopic retrograde cholangiography (1)
- endothelial cells (1)
- endovascular recanalization (1)
- endovascular thrombectomy (1)
- endovascular treatment (1)
- ensemble cNN (1)
- environmental tobacco smoke (1)
- epidural (1)
- epoxyeicosatrienoic acid (1)
- erectile dysfunction (1)
- ergonomics (1)
- everyday tasks (1)
- evidence-based guideline (1)
- exosome (1)
- extracellular vesicles (1)
- eye tracking (ET) (1)
- fMRI (1)
- fall (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- fat pad resection (1)
- feasibility study (1)
- federated feasibility queries (1)
- fibrin-glue-spray technique (1)
- fibrosis (1)
- flow cytometry (1)
- fluorescence in situ hybridization (FISH) (1)
- focal therapy (1)
- foreign body reaction (1)
- fragment screening (1)
- fragment-size analyses (ACE2; CQ11) (1)
- fungal sinusitis (1)
- gangliosides (1)
- gasotransmitters (1)
- gefitinib (1)
- gel (1)
- gene expression (1)
- gene signature (1)
- gene therapy (1)
- general practitioners (1)
- genetic variability (1)
- genome (1)
- glioblastoma survival (1)
- glioma stem-like cells (1)
- globosides (1)
- glomerulus (1)
- glucose and lipid metabolism (1)
- glucosylceramide (1)
- gravity (1)
- guided bone regeneration (1)
- guided tissue regeneration (1)
- habitat (1)
- haemophilia treatment (1)
- head and neck squamous cell carcinoma (1)
- health behavior (1)
- health care (1)
- health data (1)
- health education (1)
- health services research (1)
- health-related quality of life (1)
- healthcare system (1)
- heart failure (1)
- heart neoplasms (1)
- hematopoietic stem cell transplantation (1)
- hemorrhage (1)
- hemorrhagic transformation (1)
- hepatitis B (1)
- hepatitis B surface antigen (1)
- hepatitis C virus (1)
- hepatitis D (1)
- hidradenitis suppurativa (1)
- hierarchical clustering (1)
- high throughput screening (1)
- high-content screen (1)
- hippocampal sclerosis (1)
- histology (1)
- home training (1)
- hospital length of stay (1)
- host matrix- pathogen interaction (1)
- human MSCs (1)
- human monoclonal antibody (1)
- human research (1)
- human-liver chimeric mouse model (1)
- hybrids (1)
- hydrogen sulfide (H2S) (1)
- hyperactivity (1)
- hypertrophy (1)
- hypnotics and sedatives (1)
- hypoxia-inducible factor-2α (1)
- immune checkpoint inhibitors (ICI) (1)
- immune monitoring (1)
- immune related adverse events (irAE) (1)
- immune therapy (1)
- immunosenescence (1)
- inborn errors of immunity (1)
- indoor air (1)
- inertial motion capture (1)
- inertial sensors (1)
- infections (1)
- inflammatory bowel disease (1)
- infrapatellar fat pad (1)
- inguinal hernia (1)
- instructional film and video (1)
- insulin sensitivity (1)
- integrative medicine (1)
- interactions (1)
- interferon induction (1)
- interferon sensitivity (1)
- internet (1)
- intracellular multiplication (1)
- intrahepatic cholangiocarcinoma (1)
- intraoral scanning (1)
- invasive fungal infection (1)
- keratinized mucosa (1)
- kidney function (1)
- kinematic analysis (1)
- knee osteoarthritis (1)
- lacto/neo-lacto series GSLs (1)
- laparoscopic inguinal hernia repair (1)
- laser-induced thermotherapy (1)
- latent factor mixed model (1)
- legumain (1)
- length of stay (1)
- leukaemia (1)
- leukotriene (1)
- lipids (1)
- lipoxin (1)
- lipoxygenase inhibitor (1)
- liver (1)
- liver fibrosis (1)
- liver transplantation (1)
- local antibiotics (1)
- lockdown (1)
- long-term results (1)
- low-glycaemic meal replacement (1)
- lppr5 (1)
- lung tumor heterogeneity (1)
- lysophospholipids (1)
- lysosomal-dependent cell death (1)
- lysosome (1)
- mCRPC (1)
- mRNA (1)
- mTOR (1)
- mTORC1 (1)
- macaque (1)
- macrophage polarization (1)
- magnetic resonance imaging (1)
- mappers (1)
- mapping-algorithms (1)
- mechanical accuracy (1)
- mechanical recanalization (1)
- mechanical ventilation (1)
- medical device (1)
- medical informatics (1)
- medication management (1)
- medication review (1)
- melanoma (1)
- membrane remodeling (1)
- membranous urethra (1)
- mesangial cells (1)
- mesenchymal stromal/stem cells (1)
- metabolomics (1)
- metastases (1)
- metastasis (1)
- metastatic prostate cancer (1)
- miR (1)
- microbial colonization (1)
- microbiology (1)
- microlaparoscopy (1)
- microstimulation (1)
- microwave ablation (1)
- mid-term urinary continence (1)
- mineralization (1)
- minimal invasive (1)
- minimally invasive surgery (1)
- mitochondria (1)
- mixed infection (1)
- model builder software (1)
- modelling (1)
- molecular diagnostic techniques (1)
- molecular subtyping (1)
- molecular typing (1)
- monitoring (1)
- monocytes (1)
- mortality (1)
- mouthwash (1)
- mouthwash solution (1)
- multicentre study (1)
- multidrug resistance (1)
- multidrug resistance protein 4 (1)
- multiparametric magnetic resonance imaging (1)
- multiple myeloma (1)
- multiple sclerosis (1)
- multiplex immunohistochemistry (1)
- multiplexed immunofluorescence (1)
- multispectral flow cytometry (1)
- musculoskeletal disorders (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant chemotherapy (1)
- neoadjuvant immunochemotherapy (1)
- neoplasm metastasis (1)
- nephropathy (1)
- nerve-sparing surgery (1)
- neuroblast (1)
- neurocognition (1)
- neurocognitive outcome (1)
- neurocritical care (1)
- neuroendocrine (1)
- neurological complication (1)
- neurological side effects (1)
- neurooncology (1)
- neuropathy (1)
- neurysmal subarachnoid hemorrhage (aSAH) (1)
- neutralization (1)
- neutropenia (1)
- neutrophil elastase (1)
- newly diagnosed glioblastoma (1)
- nitric oxide (1)
- noise (1)
- non-neutropenic episode (1)
- non-organ confined stage (1)
- non-small-cell lung cancer (1)
- non-surgical periodontal therapy (1)
- nonsense-mediated mRNA decay (1)
- normal liver cells (1)
- novel technologies (1)
- nuclear receptor (1)
- nuclear receptor-related 1 (1)
- obstetric pain (1)
- obstetrics (1)
- oedema (1)
- olfaction (1)
- olfactory testing (1)
- olive mill wastewater (OMWW) (1)
- open (1)
- oral cavity cancer (1)
- oral drug products (1)
- osteoblast (1)
- osteoclasts (1)
- osteogenic differentiation (1)
- outbreak (1)
- outpatient care (1)
- outpatients (1)
- overall survival (1)
- oxidative phosphorylation (1)
- p16 (1)
- pain management (1)
- parabolic flight (1)
- passive smoke (1)
- pathogenicity (1)
- patient centered care (1)
- patient data (1)
- patient-centred care (1)
- patient-reported outcomes (1)
- pediatric robotic surgery (1)
- pembrolizumab (1)
- percutaneous thermal ablation (1)
- peri-implant diseases (1)
- peri-implantitis (1)
- periodontal– systemic disease interactions (1)
- peripheral injury (1)
- phantom study (1)
- pharmacophore model (1)
- phase I (1)
- phosphatidylethanolamines (1)
- phospholipid (1)
- phosphorylation (1)
- physical activity (1)
- physical performance (1)
- pimozide (1)
- platinum-based chemotherapy (1)
- plppr5 (1)
- pole concept of goiter growth (1)
- portal vein (1)
- posterior horn (1)
- posteroinferior horn (1)
- postgraduate edu (1)
- postnatal care (1)
- postoperative pain (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- prediction (1)
- predictive (1)
- predictive biomarker (1)
- predictor (1)
- prenatal diagnostic (1)
- prevention (1)
- preventive health services (1)
- primary care (1)
- primary health care (1)
- print and press (1)
- private brands (1)
- product performance (1)
- professional soccer players (1)
- prognosis (1)
- prognostic (1)
- prone position (1)
- propensity score matching (1)
- prostaglandin (1)
- prostaglandins (1)
- prostate neoplasia (1)
- prostatectomy (1)
- proteasomal processing escape (1)
- proteasome (1)
- protein-rich (1)
- prothrombin induced by vitamin K absence-II (1)
- pulmonary embolism (1)
- pulmonary failure (1)
- pulmonary ventilation (1)
- pulsed-field (1)
- purification (1)
- qualitative research (1)
- query (1)
- race/ethnicity disparities (1)
- radiation (1)
- radiotherapy (1)
- range expansion (1)
- rat model (1)
- rats (1)
- re-exposure (1)
- reactive oxygen species (1)
- real world (1)
- realist synthesis (1)
- rechallenge (1)
- recurrence pattern (1)
- recurrent cholangitis (1)
- refractive lens exchange (1)
- refractive surgery (1)
- reintroduction (1)
- renal fibroblasts (1)
- renal inflammation (1)
- resistant cell lines (1)
- resolvin (1)
- respiratory failure (1)
- respiratory infections (1)
- resveratrol (1)
- rheumatoid arthritis (1)
- rhinovirus (1)
- rifampin (1)
- risk assessment (1)
- risk of malignancy (1)
- robot-guided stereotaxy (1)
- robotic-assisted (1)
- robotically assisted surgery (1)
- robotics (1)
- seasonal adaption (1)
- seizure (1)
- seizures (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- shape (1)
- short-course antibiotic therapy (1)
- siRNA lipid nanoparticles (LNPs) (1)
- single-cell RNA sequencing (1)
- single-cell proteomics (1)
- sleep quality (1)
- smoking behavior (1)
- social recognition (1)
- soft tissue (1)
- sound localization (1)
- speech and language pathologist (1)
- speech perception (1)
- sphingosine (1)
- sphingosine 1-phosphate (1)
- sphingosine 1-phosphate homologues (1)
- sphingosine-1-phosphate (1)
- spinal metastasis (1)
- stairs (1)
- stakeholder analysis (1)
- statistics (1)
- stent patency (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stomach neoplasms (1)
- store brands (1)
- study protocol (1)
- subchondral bone (1)
- subdural hematoma (1)
- sulfatides (1)
- sunitinib (1)
- surgical procedures (1)
- swarming (1)
- sympathetic (1)
- synovium (1)
- taller-than-wide (1)
- targeted therapy (1)
- temporal lobe epilepsy (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapeutics (1)
- thrombin (1)
- thrombosis (1)
- thrombospondins (1)
- thromboxane (1)
- tight junctions (1)
- tissue engineering (1)
- tooth loss (1)
- tooth transplantation (1)
- toric intraocular lens (1)
- total knee replacement (1)
- trans (1)
- transcription factors (1)
- transcriptional cyclin-dependent kinase (1)
- transcriptomics (1)
- translatomics (1)
- trauma (1)
- treatment centres (1)
- triglycerides (1)
- trimeric autotransporters adhesin (1)
- tumor (1)
- tumor growth (1)
- ubiquitin (1)
- unmethylated MGMT (1)
- upgrading (1)
- upstaging (1)
- urethral stricture (1)
- urinary incontinence (1)
- urothelial carcinoma (1)
- v-ATPase (1)
- variant of concern (1)
- vascular integrity (1)
- vemurafenib (1)
- viral replication (1)
- virologic failure (1)
- visual cortex (1)
- visual search (VS) (1)
- wastewater-based epidemiology (WBE) (1)
- weight reduction (1)
- whole genome pooled sequencing (1)
- workflow development (1)
- yellow fever mosquito (1)
Institute
- Medizin (386)
- Biochemie, Chemie und Pharmazie (10)
- Biowissenschaften (8)
- Frankfurt Institute for Advanced Studies (FIAS) (6)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (5)
- Georg-Speyer-Haus (5)
- Ernst Strüngmann Institut (3)
- Informatik und Mathematik (3)
- MPI für Biophysik (3)
- Psychologie und Sportwissenschaften (3)
Purpose: Recent studies demonstrated a contribution of adrenoceptors (ARs) to osteoarthritis (OA) pathogenesis. Several AR subtypes are expressed in joint tissues and the β2-AR subtype seems to play a major role during OA progression. However, the importance of β2-AR has not yet been investigated in knee OA. Therefore, we examined the development of knee OA in β2-AR-deficient (Adrb2-/-) mice after surgical OA induction.
Methods: OA was induced by destabilization of the medial meniscus (DMM) in male wildtype (WT) and Adrb2-/- mice. Cartilage degeneration and synovial inflammation were evaluated by histological scoring. Subchondral bone remodeling was analyzed using micro-CT. Osteoblast (alkaline phosphatase - ALP) and osteoclast (cathepsin K - CatK) activity were analyzed by immunostainings. To evaluate β2-AR deficiency-associated effects, body weight, sympathetic tone (splenic norepinephrine (NE) via HPLC) and serum leptin levels (ELISA) were determined. Expression of the second major AR, the α2-AR, was analyzed in joint tissues by immunostaining.
Results: WT and Adrb2-/- DMM mice developed comparable changes in cartilage degeneration and synovial inflammation. Adrb2-/- DMM mice displayed elevated calcified cartilage and subchondral bone plate thickness as well as increased epiphyseal BV/TV compared to WTs, while there were no significant differences in Sham animals. In the subchondral bone of Adrb2-/- mice, osteoblasts activity increased and osteoclast activity deceased. Adrb2-/- mice had significantly higher body weight and fat mass compared to WT mice. Serum leptin levels increased in Adrb2-/- DMM compared to WT DMM without any difference between the respective Shams. There was no difference in the development of meniscal ossicles and osteophytes or in the subarticular trabecular microstructure between Adrb2-/- and WT DMM as well as Adrb2-/- and WT Sham mice. Number of α2-AR-positive cells was lower in Adrb2-/- than in WT mice in all analyzed tissues and decreased in both Adrb2-/- and WT over time.
Conclusion: We propose that the increased bone mass in Adrb2-/- DMM mice was not only due to β2-AR deficiency but to a synergistic effect of OA and elevated leptin concentrations. Taken together, β2-AR plays a major role in OA-related subchondral bone remodeling and is thus an attractive target for the exploration of novel therapeutic avenues.
Mutations in the Von Hippel–Lindau (VHL) gene are the driving force in many forms of clear cell renal cell carcinoma (ccRCC) and promote hypoxia-inducible factor (HIF)-dependent tumor proliferation, metastasis and angiogenesis. Despite the progress that has already been made, ccRCC generally remain resistant to conventional therapies and ccRCC patients suffer from metastasis and acquired resistance, highlighting the need for novel therapeutic options. Cysteinyl leukotriene receptor 1 (CysLTR1) antagonists, like zafirlukast, are administered in bronchial asthma to control eicosanoid signaling. Intriguingly, long-term use of zafirlukast decreases cancer risk and leukotriene receptor antagonists inhibit tumor growth, but the mechanisms still remain unexplored. Therefore, we aim to understand the mechanisms of zafirlukast-mediated cell death in ccRCC cells. We show that zafirlukast induces VHL-dependent and TNFα-independent non-apoptotic and non-necroptotic cell death in ccRCC cells. Cell death triggered by zafirlukast could be rescued with antioxidants and the PARP-1 inhibitor Olaparib, and additionally relies on HIF-2α. Finally, MG-132-mediated proteasome inhibition sensitized VHL wild-type cells to zafirlukast-induced cell death and inhibition of HIF-2α rescued zafirlukast- and MG-132-triggered cell death. Together, these results highlight the importance of VHL, HIF and proteasomal degradation in zafirlukast-induced oxidative cell death with potentially novel therapeutic implications for ccRCC.
Myocardial injury as induced by myocardial infarction results in tissue ischemia, which critically incepts cardiomyocyte death. Endothelial cells play a crucial role in restoring oxygen and nutrient supply to the heart. Latest advances in single-cell multi-omics, together with genetic lineage tracing, reveal a transcriptional and phenotypical adaptation to the injured microenvironment, which includes alterations in metabolic, mesenchymal, hematopoietic and pro-inflammatory signatures. The extent of transition in mesenchymal or hematopoietic cell lineages is still debated, but it is clear that several of the adaptive phenotypical changes are transient and endothelial cells revert back to a naïve cell state after resolution of injury responses. This resilience of endothelial cells to acute stress responses is important for preventing chronic dysfunction. Here, we summarize how endothelial cells adjust to injury and how this dynamic response contributes to repair and regeneration. We will highlight intrinsic and microenvironmental factors that contribute to endothelial cell resilience and may be targetable to maintain a functionally active, healthy microcirculation.
The current management of a primary IgE-mediated peanut allergy consists of the two basic pillars “exposure prophylaxis” with avoidance of the allergen and “emergency therapy” with short-term treatment of an acute allergic reaction after accidental ingestion. Accidental reactions are common despite attempted avoidance. The severity of an allergic or even anaphylactic reaction after accidental ingestion is difficult to assess prior to reaction. In addition, reaction thresholds may vary depending on the accompanying augmentation factor. Therefore, every peanut allergic patient should receive individual dietary counseling as well as instructions for the use of the emergency kit and a structured patient education program (anaphylaxis group training), if necessary. For the first time, since fall 2021 a causal treatment option with a drug for oral immunotherapy will now be available for 4‑ to 17-year-old peanut-allergic children and adolescents. The oral immunotherapy with peanut protein as defatted powder of Arachis hypogaea L., semen (peanuts) leads to desensitization with a good efficacy record and an acceptable safety profile. Other treatment options with different therapeutic approaches are also under development and will probably expand the range for treatment in the coming years.
White paper peanut allergy
(2022)
The current management of a primary IgE-mediated peanut allergy consists of the two basic pillars “exposure prophylaxis” with avoidance of the allergen and “emergency therapy” with short-term treatment of an acute allergic reaction after accidental ingestion. Accidental reactions are common despite attempted avoidance. The severity of an allergic or even anaphylactic reaction after accidental ingestion is difficult to assess prior to reaction. In addition, reaction thresholds may vary depending on the accompanying augmentation factor. Therefore, every peanut allergic patient should receive individual dietary counseling as well as instructions for the use of the emergency kit and a structured patient education program (anaphylaxis group training), if necessary. For the first time, since fall 2021 a causal treatment option with a drug for oral immunotherapy will now be available for 4‑ to 17-year-old peanut-allergic children and adolescents. The oral immunotherapy with peanut protein as defatted powder of Arachis hypogaea L., semen (peanuts) leads to desensitization with a good efficacy record and an acceptable safety profile. Other treatment options with different therapeutic approaches are also under development and will probably expand the range for treatment in the coming years.
Background: Increasing numbers of patients surviving malignant bone tumors around the knee joint have led to an increasing importance to investigate long-term results. This study assessed the long-term results of rotationplasty after resection of malignant bone tumors regarding functional outcome and quality of life to allow better comparison with other treatment options in bone cancer treatment.
Procedure: 60 participants who underwent rotationplasty due to bone cancer took part in this multicentric questionnaire- based study. The long-term functional outcome was measured by the Musculoskeletal tumor society score (MSTS) and the Tegner activity level scale. The health-related quality of life (HRQL) was assessed by using the Short Form Health Survey (SF-36).
Results: Patients treated with rotationplasty (median follow- up of 22 years, range 10–47 years) regained a high level of activity (median MSTS score of 24). Even a return to high level sports was possible (mean Tegner activity level scale of 4). Duration of follow-up did not influence the functional outcome. HRQL scores were comparable to the general German popula tion. Concerns of psychological problems due to the unusual appearance of the rotated foot have not been confirmed.
Conclusion: Rotationplasty can be a good alternative to en- doprosthetic replacement or amputation, either as primary surgery or as a salvage procedure. Especially for growing children and very active patients rotationplasty should be considered.
Wastewater-based epidemiology (WBE) has demonstrated its importance to support SARS-CoV-2 epidemiology complementing individual testing strategies. Due to their immune-evasive potential and the resulting significance for public health, close monitoring of SARS-CoV-2 variants of concern (VoC) is required to evaluate the regulation of early local countermeasures. In this study, we demonstrate a rapid workflow for wastewater-based early detection and monitoring of the newly emerging SARS-CoV-2 VoCs Omicron in the end of 2021 at the municipal wastewater treatment plant (WWTP) Emschermuendung (KLEM) in the Federal State of North-Rhine-Westphalia (NRW, Germany).
Initially, available primers detecting Omicron-related mutations were rapidly validated in a central laboratory. Subsequently, RT-qPCR analysis of purified SARS-CoV-2 RNA was performed in a decentral PCR laboratory in close proximity to KLEM. This decentralized approach enabled the early detection of K417N present in Omicron in samples collected on 8th December 2021 and the detection of further mutations (N501Y, Δ69/70) in subsequent biweekly sampling campaigns. The presence of Omicron in wastewater was confirmed by next generation sequencing (NGS) in a central laboratory with samples obtained on 14th December 2021. Moreover, the relative increase of the mutant fraction of Omicron was quantitatively monitored over time by dPCR in a central PCR laboratory starting on 12th December 2021 confirming Omicron as the dominant variant by the end of 2021.
In conclusions, WBE plays a crucial role in surveillance of SARS-CoV-2 variants and is suitable as an early warning system to identify variant emergence. In particular, the successive workflow using RT-qPCR, RT-dPCR and NGS demonstrates the strength of WBE as a versatile tool to monitor variant spreading.
Aims: Understanding the orientation of fracture lines and mechanisms is the essential key to sufficient surgical therapy, but there is still a lack of visualization and teaching methods in traumatology and fracture theory. 3D-printed models offer easy approach to those fractures. This paper explains the use of the teaching possibility with 3-dimensional models of transitional fractures of the ankle.
Methods and results: For generating 3D printable models, already obtained CT data were used and segmented into its different tissues, especially parts concerning the fracture. After the segmentation process, the models were produced with FFF (fused filament fabrication) printing technology. The fracture models then were used for hands-on teaching courses in AO course (Arbeitsgemeinschaft für Osteosynthesefragen) of pediatric traumatology in 2020 in Frankfurt. In the course fracture anatomy with typical fracture lines, approaches, and screw placement could be shown, discussed and practiced.
Conclusion: The study shows the use of 3D-printed teaching models and helps to understand complicated fractures, in this case, transitional fractures of the ankle. The teaching method can be adapted to numerous other use cases.
Background: Standardized neuropsychological testing serves to quantify cognitive impairment in multiple sclerosis (MS) patients. However, the exact mechanism underlying the translation of cognitive dysfunction into difficulties in everyday tasks has remained unclear. To answer this question, we tested if MS patients with intact vs. impaired information processing speed measured by the Symbol Digit Modalities Test (SDMT) differ in their visual search behavior during ecologically valid tasks reflecting everyday activities.
Methods: Forty-three patients with relapsing-remitting MS enrolled in an eye-tracking experiment consisting of a visual search task with naturalistic images. Patients were grouped into “impaired” and “unimpaired” according to their SDMT performance. Reaction time, accuracy and eye-tracking parameters were measured.
Results: The groups did not differ regarding age, gender, and visual acuity. Patients with impaired SDMT (cut-off SDMT-z-score < −1.5) performance needed more time to find and fixate the target (q = 0.006). They spent less time fixating the target (q = 0.042). Impaired patients had slower reaction times and were less accurate (both q = 0.0495) even after controlling for patients' upper extremity function. Exploratory analysis revealed that unimpaired patients had higher accuracy than impaired patients particularly when the announced target was in unexpected location (p = 0.037). Correlational analysis suggested that SDMT performance is inversely linked to the time to first fixation of the target only if the announced target was in its expected location (r = −0.498, p = 0.003 vs. r = −0.212, p = 0.229).
Conclusion: Dysfunctional visual search behavior may be one of the mechanisms translating cognitive deficits into difficulties in everyday tasks in MS patients. Our results suggest that cognitively impaired patients search their visual environment less efficiently and this is particularly evident when top-down processes have to be employed.
Sudden cardiac death (SCD) in adolescents and young adults may be the first manifestation of an inherited arrhythmic syndrome. Thus identification of a genetic origin in sudden death cases deemed inconclusive after a comprehensive autopsy and may help to reduce the risk of lethal episodes in the remaining family. Using next-generation sequencing (NGS), a large number of variants of unknown significance (VUS) are detected. In the majority of cases, there is insufficient evidence of pathogenicity, representing a huge dilemma in current genetic investigations. Misinterpretation of such variants may lead to inaccurate genetic diagnoses and/or the adoption of unnecessary and/or inappropriate therapeutic approaches. In our study, we applied current (ACMG) recommendations for variant classification in post-mortem genetic screening of a cohort of 56 SCD victims. We identified a total 53 rare protein-altering variants (MAF < 0.2%) classified as VUS or worse. Twelve percent of the cases exhibited a clinically actionable variant (pathogenic, likely pathogenic or VUS – potentially pathogenic) that would warrant cascade genetic screening in relatives. Most of the variants detected by means of the post-mortem genetic investigations were VUS. Thus, genetic testing by itself might be fairly meaningless without supporting background data. This data reinforces the need for an experienced multidisciplinary team for obtaining reliable and accountable interpretations of variant significance for elucidating potential causes for SCDs in the young. This enables the early identification of relatives at risk or excludes family members as genetic carriers. Also, development of adequate forensic guidelines to enable appropriate interpretation of rare genetic variants is fundamental.
Highlights
• USP32 deubiquitinates the Ragulator complex subunit LAMTOR1 at lysine (K) 20
• LAMTOR1 K20 ubiquitination impairs its binding to the vacuolar H+-ATPase
• USP32 knockout reduces mTORC1 activity and elevates autophagic flux
• Depletion of USP32 in Caenorhabditis elegans inhibits mTOR and induces autophagy
Summary
The endosomal-lysosomal system is a series of organelles in the endocytic pathway that executes trafficking and degradation of proteins and lipids and mediates the internalization of nutrients and growth factors to ensure cell survival, growth, and differentiation. Here, we reveal regulatory, non-proteolytic ubiquitin signals in this complex system that are controlled by the enigmatic deubiquitinase USP32. Knockout (KO) of USP32 in primary hTERT-RPE1 cells results among others in hyperubiquitination of the Ragulator complex subunit LAMTOR1. Accumulation of LAMTOR1 ubiquitination impairs its interaction with the vacuolar H+-ATPase, reduces Ragulator function, and ultimately limits mTORC1 recruitment. Consistently, in USP32 KO cells, less mTOR kinase localizes to lysosomes, mTORC1 activity is decreased, and autophagy is induced. Furthermore, we demonstrate that depletion of USP32 homolog CYK-3 in Caenorhabditis elegans results in mTOR inhibition and autophagy induction. In summary, we identify a control mechanism of the mTORC1 activation cascade at lysosomes via USP32-regulated LAMTOR1 ubiquitination.
Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting with the inactivation of tumour suppressors and subsequent development of activating mutations in proto-oncogenes, such as members of the PI3K or MAPK families. Cells undergoing transformation have to adjust to changes, including altered metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors. Here, we report that the ubiquitin carboxyl-terminal hydrolase 28 (USP28) enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes such as c-JUN, c-MYC, NOTCH and ∆NP63 at early stages of malignant transformation. USP28 levels are increased in cancer compared with in normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small-molecule inhibitor resets the proteome of transformed cells towards a ‘premalignant’ state, and its inhibition synergizes with clinically established compounds used to target EGFRL858R-, BRAFV600E- or PI3KH1047R-driven tumour cells. Targeting USP28 protein abundance at an early stage via inhibition of its activity is therefore a feasible strategy for the treatment of early-stage lung tumours, and the observed synergism with current standard-of-care inhibitors holds the potential for improved targeting of established tumours.
Background: A growing interest exists in using polymeric nanoparticles (NPs) especially functionalized with surface-active substances as carriers across the blood brain barrier (BBB) for potentially effective drugs in traumatic brain injury (TBI). However, the organ distribution of intravenous administrated biodegradable and non-biodegradable NPs coated with different surfactants, how much of the administrated dose reach the brain parenchyma in areas with intact and opened BBB after trauma, as well as whether they elicit an inflammatory response is still to be clarified.
Methods: The organ distribution, brain penetration and eventual inflammatory activation of polysorbate-80 (Tw80) and sodium-lauryl-sulfate (SDS) coated poly l-lactide (PLLA) and perfluorodecyl acrylate (PFDL) nanoparticles were evaluated after intravenous administration in rats prior and after undergoing controlled cortical impact (CCI).
Results: A significant highest NP uptake at 4 and 24 hs was observed in the liver and spleen, followed by the brain and kidney, with minimal concentrations in the lungs and heart for all NPs. After CCI, a significant increase of NP uptake at 4 hs and 24 hs was observed within the traumatized hemisphere, especially in the perilesional area, although NPs were still found in areas away from CCI and the contralateral hemisphere in similar concentrations as in non-CCI subject. NPs were localized in neurons, glial and endovascular cells. Immunohistochemical staining against GFAP, Iba1, TNFα and IL1β demonstrated no glial activation or neuroinflamatory changes.
Conclusions: Tw80 and SDS coated biodegradable (PLLA) and non-biodegradrable (PFDL) NPs reach the brain parenchyma in both areas of traumatized and undamaged brain with disrupted and intact BBB, even though a high amount of them are retained in the liver and the spleen. No inflammatory reaction is elicited by these NPs within 24 hs after application. These preliminary promising results postulate the effectiveness and safety of these NPs as drug-carriers for the treatment of TBI.
Background: Interventional studies on polypharmacy often fail to significantly improve patient-relevant outcomes, or confine themselves to measuring surrogate parameters. Interventions and settings are complex, with many factors affecting results. The AdAM study’s aim is to reduce hospitalization and death by requiring general practitioners (GPs) to use a computerized decision-support system (CDSS). The study will undergo a process evaluation to identify factors for successful implementation and to assess whether the intervention was implemented as intended.
Objective: To evaluate our complex intervention, based on the Medical Research Council’s guideline dimensions.
Research Questions:
We will assess implementation (reach, fidelity, dose, tailoring) by asking: (1) Who took part in the intervention (proportion of GPs using the CDSS, proportion of patients enrolled in them)? Information on GPs’ and patients’ characteristics will also be collected. (2) How many and which medication alerts were dealt with? (3) Was the intervention implemented as intended? (4) On what days did GPs use the intervention tool?
Methods: The process evaluation is part of a stepped-wedge cluster-randomized controlled trial. Characteristics of practices, GPs and patients using the CDSS will be compared with the non-participating population. CDSS log data will be analyzed to evaluate how the number of medication alerts changed between baseline and 2 months later, and to identify the kind of alerts that were dealt with. Comparison of enrolled patients on weekdays versus weekends will shed light on GPs’ use of the CDSS in the absence or presence of patients. Outcomes will be presented using descriptive statistics, and significance tests will be used to identify associations between them. We will conduct subgroup analyses, including time effects to account for software improvements.
Discussion: This study protocol is the basis for conducting analyses of the quantitative process evaluation. By providing insight into how GPs conduct medication reviews, the evaluation will provide context to the trial results and support their interpretation. The evaluation relies on the proper documentation by GPs, potentially limiting its explanatory power.
Polypharmacy is associated with a risk of negative health outcomes. Potentially inappropriate medications, interactions resulting from contradicting medical guidelines, and inappropriate monitoring, all increase the risk. This process evaluation (PE) of the AdAM study investigates implementation and use of a computerized decision-support system (CDSS). The CDSS analyzes medication appropriateness by including claims data, and hence provides general practitioners (GPs) with full access to patients’ medical treatments. We based our PE on pseudonymized logbook entries into the CDSS and used the four dimensions of the Medical Research Council PE framework. Reach, which examines the extent to which the intended study population was included, and Dose, Fidelity, and Tailoring, which examine how the software was actually used by GPs. The PE was explorative and descriptive. Study participants were representative of the target population, except for patients receiving a high level of nursing care, as they were treated less frequently. GPs identified and corrected inappropriate prescriptions flagged by the CDSS. The frequency and intensity of interventions documented in the form of logbook entries lagged behind expectations, raising questions about implementation barriers to the intervention and the limitations of the PE. Impossibility to connect the CDSS to GPs’ electronic medical records (EMR) of GPs due to technical conditions in the German healthcare system may have hindered the implementation of the intervention. Data logged in the CDSS may underestimate medication changes in patients, as documentation was voluntary and already included in EMR.
Background: To test the impact of urethral sphincter length (USL) and anatomic variants of prostatic apex (Lee-type classification) in preoperative multiparametric magnet resonance imaging (mpMRI) on mid-term continence in prostate cancer patients treated with radical prostatectomy (RP). Methods: We relied on an institutional tertiary-care database to identify patients who underwent RP between 03/2018 and 12/2019 with preoperative mpMRI and data available on mid-term (>6 months post-surgery) urinary continence, defined as usage 0/1 (-safety) pad/24 h. Univariable and multivariable logistic regression models were fitted to test for predictor status of USL and prostatic apex variants, defined in mpMRI measurements. Results: Of 68 eligible patients, rate of mid-term urinary continence was 81% (n = 55). Median coronal (15.1 vs. 12.5 mm) and sagittal (15.4 vs. 11.1 mm) USL were longer in patients reporting urinary continence in mid-term follow-up (both p < 0.01). No difference was recorded for prostatic apex variants distribution (Lee-type) between continent vs. incontinent patients (p = 0.4). In separate multivariable logistic regression models, coronal (odds ratio (OR): 1.35) and sagittal (OR: 1.67) USL, but not Lee-type, were independent predictors for mid-term continence. Conclusion: USL, but not apex anatomy, in preoperative mpMRI was associated with higher rates of urinary continence at mid-term follow-up.
Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer. Low numbers of HCC patients being suitable for liver resection or transplantation and multidrug resistance development during pharmacotherapy leads to high death rates for HCC patients. Understanding the molecular mechanisms of HCC etiology may contribute to the development of novel therapeutic strategies for prevention and treatment of HCC. UDP-glucose ceramide glycosyltransferase (UGCG), a key enzyme in glycosphingolipid metabolism, generates glucosylceramide (GlcCer), which is the precursor for all glycosphingolipids (GSLs). Since UGCG gene expression is altered in 0.8% of HCC tumors, GSLs may play a role in cellular processes in liver cancer cells. Here, we discuss the current literature about GSLs and their abundance in normal liver cells, Gaucher disease and HCC. Furthermore, we review the involvement of UGCG/GlcCer in multidrug resistance development, globosides as a potential prognostic marker for HCC, gangliosides as a potential liver cancer stem cell marker, and the role of sulfatides in tumor metastasis. Only a limited number of molecular mechanisms executed by GSLs in HCC are known, which we summarize here briefly. Overall, the role GSLs play in HCC progression and their ability to serve as biomarkers or prognostic indicators for HCC, requires further investigation.
Background: Up- and/or downgrading rates in single intermediate-risk positive biopsy core are unknown.
Methods: We identified single intermediate-risk (Gleason grade group (GGG) 2/GGG3) positive biopsy core prostate cancer patients (≤ cT2c and PSA ≤ 20 ng/mL) within the Surveillance, Epidemiology, and End Results (SEER) database (2010–2015). Subsequently, separate uni- and multivariable logistic regression models tested for independent predictors of up- and downgrading.
Results: Of 1,328 assessable patients with single core positive intermediate-risk prostate cancer at biopsy, 972 (73%) harbored GGG2 versus 356 (27%) harbored GGG3. Median PSA (5.5 vs 5.7; p = 0.3), median age (62 vs 63 years; p = 0.07) and cT1-stage (77 vs 75%; p = 0.3) did not differ between GGG2 and GGG3 patients. Of individuals with single GGG2 positive biopsy core, 191 (20%) showed downgrading to GGG1 versus 35 (4%) upgrading to GGG4 or GGG5 at RP. Of individuals with single GGG3 positive biopsy core, 36 (10%) showed downgrading to GGG1 versus 42 (12%) significant upgrading to GGG4 or GGG5 at RP. In multivariable logistic regression models, elevated PSA (10–20 ng/mL) was an independent predictor of upgrading to GGG4/GGG5 in single GGG3 positive biopsy core patients (OR:2.89; 95%-CI: 1.31–6.11; p = 0.007).
Conclusion: In single GGG2 positive biopsy core patients, downgrading was four times more often recorded compared to upgrading. Conversely, in single GGG3 positive biopsy core patients, up- and downgrading rates were comparable and should be expected in one out of ten patients.
Introduction: Despite improvements in medical science and public health, mortality of community-acquired pneumonia (CAP) has barely changed throughout the last 15 years. The current SARS-CoV-2 pandemic has once again highlighted the central importance of acute respiratory infections to human health. The “network of excellence on Community Acquired Pneumonia” (CAPNETZ) hosts the most comprehensive CAP database worldwide including more than 12,000 patients. CAPNETZ connects physicians, microbiologists, virologists, epidemiologists, and computer scientists throughout Europe. Our aim was to summarize the current situation in CAP research and identify the most pressing unmet needs in CAP research.
Methods: To identify areas of future CAP research, CAPNETZ followed a multiple-step procedure. First, research members of CAPNETZ were individually asked to identify unmet needs. Second, the top 100 experts in the field of CAP research were asked for their insights about the unmet needs in CAP (Delphi approach). Third, internal and external experts discussed unmet needs in CAP at a scientific retreat.
Results: Eleven topics for future CAP research were identified: detection of causative pathogens, next generation sequencing for antimicrobial treatment guidance, imaging diagnostics, biomarkers, risk stratification, antiviral and antibiotic treatment, adjunctive therapy, vaccines and prevention, systemic and local immune response, comorbidities, and long-term cardio-vascular complications.
Conclusion: Pneumonia is a complex disease where the interplay between pathogens, immune system and comorbidities not only impose an immediate risk of mortality but also affect the patients’ risk of developing comorbidities as well as mortality for up to a decade after pneumonia has resolved. Our review of unmet needs in CAP research has shown that there are still major shortcomings in our knowledge of CAP.
Significant advances have been made by identifying the levels of synchrony of the underlying dynamics of a given brain state. This research has demonstrated that non-conscious dynamics tend to be more synchronous than in conscious states, which are more asynchronous. Here we go beyond this dichotomy to demonstrate that different brain states are underpinned by dissociable spatiotemporal dynamics. We investigated human neuroimaging data from different brain states (resting state, meditation, deep sleep and disorders of consciousness after coma). The model-free approach was based on Kuramoto’s turbulence framework using coupled oscillators. This was extended by a measure of the information cascade across spatial scales. Complementarily, the model-based approach used exhaustive in silico perturbations of whole-brain models fitted to these measures. This allowed studying of the information encoding capabilities in given brain states. Overall, this framework demonstrates that elements from turbulence theory provide excellent tools for describing and differentiating between brain states.
LFA-1 (Lymphocyte function-associated antigen-1) is a heterodimeric integrin (CD11a/CD18) present on the surface of all leukocytes; it is essential for leukocyte recruitment to the site of tissue inflammation, but also for other immunological processes such as T cell activation and formation of the immunological synapse. Absent or dysfunctional expression of LFA-1, caused by mutations in the ITGB2 (integrin subunit beta 2) gene, results in a rare immunodeficiency syndrome known as Leukocyte adhesion deficiency type I (LAD I). Patients suffering from severe LAD I present with recurrent infections of the skin and mucosa, as well as inflammatory symptoms complicating the clinical course of the disease before and after allogeneic hematopoietic stem cell transplantation (alloHSCT); alloHSCT is currently the only established curative treatment option. With this review, we aim to provide an overview of the intrinsic role of inflammation in LAD I.
Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Legionnaires’ disease continues to present an ongoing public health concern. Legionella’s virulence is based on its ability to simultaneously hijack multiple molecular pathways of the host cell to ensure its fast replication and dissemination. Legionella usurps the host ubiquitin system through multiple effector proteins, using the advantage of both conventional and unconventional (phosphoribosyl-linked) ubiquitination, thus providing optimal conditions for its replication. In this review, we summarize the current understanding of L. pneumophila from medical, biochemical and molecular perspectives. We describe the clinical disease presentation, its diagnostics and treatment, as well as host-pathogen interactions, with the emphasis on the ability of Legionella to target the host ubiquitin system upon infection. Furthermore, the interdisciplinary use of innovative technologies enables better insights into the pathogenesis of Legionnaires’ disease and provides new opportunities for its treatment and prevention.
Purpose: Total body irradiation (TBI) is a common part of the myelo- and immuno-ablative conditioning regimen prior to an allogeneic hematopoietic stem cell transplantation (allo-HSCT). Due to concerns regarding acute and long-term complications, there is currently a decline in otherwise successfully established TBI-based conditioning regimens. Here we present an analysis of patient and treatment data with focus on survival and long-term toxicity.
Methods: Patients with hematologic diseases who received TBI as part of their conditioning regimen prior to allo-HSCT at Frankfurt University Hospital between 1997 and 2015 were identified and retrospectively analyzed.
Results: In all, 285 patients with a median age of 45 years were identified. Median radiotherapy dose applied was 10.5 Gy. Overall survival at 1, 2, 5, and 10 years was 72.6, 64.6, 54.4, and 51.6%, respectively. Median follow-up of patients alive was 102 months. The cumulative incidence of secondary malignancies was 12.3% (n = 35), with hematologic malignancies and skin cancer predominating. A TBI dose ≥ 8 Gy resulted in significantly improved event-free (p = 0.030) and overall survival (p = 0.025), whereas a total dose ≤ 8 Gy and acute myeloid leukemia (AML) diagnosis were associated with significantly increased rates of secondary malignancies (p = 0.003, p = 0.048) in univariate analysis. No significant correlation was observed between impaired renal or pulmonary function and TBI dose.
Conclusion: TBI remains an effective and well-established treatment, associated with distinct late-toxicity. However, in the present study we cannot confirm a dose–response relationship in intermediate dose ranges. Survival, occurrence of secondary malignancies, and late toxicities appear to be subject to substantial confounding in this context.
Penile squamous cell carcinomas are rare tumor entities throughout Europe. Early lymphonodal spread urges for aggressive therapeutic approaches in advanced tumor stages. Therefore, understanding tumor biology and its microenvironment and correlation with known survival data is of substantial interest in order to establish treatment strategies adapted to the individual patient. Fifty-five therapy naïve squamous cell carcinomas, age range between 41 and 85 years with known clinicopathological data, were investigated with the use of tissue microarrays (TMA) regarding the tumor-associated immune cell infiltrate density (ICID). Slides were stained with antibodies against CD3, CD8 and CD20. An image analysis software was applied for evaluation. Data were correlated with clinicopathological characteristics and overall survival. There was a significant increase of ICID in squamous cell carcinomas of the penis in relation to tumor adjacent physiological tissue. Higher CD3-positive ICID was significantly associated with lower tumor stage in our cohort. The ICID was not associated with overall survival. Our data sharpens the view on tumor-associated immune cell infiltrate in penile squamous cell carcinomas with an unbiased digital and automated cell count. Further investigations on the immune cell infiltrate and its prognostic and possible therapeutic impact are needed.
Objective: This study was undertaken to calculate epilepsy-related direct, indirect, and total costs in adult patients with active epilepsy (ongoing unprovoked seizures) in Germany and to analyze cost components and dynamics compared to previous studies from 2003, 2008, and 2013. This analysis was part of the Epi2020 study.
Methods: Direct and indirect costs related to epilepsy were calculated with a multicenter survey using an established and validated questionnaire with a bottom-up design and human capital approach over a 3-month period in late 2020. Epilepsy-specific costs in the German health care sector from 2003, 2008, and 2013 were corrected for inflation to allow for a valid comparison.
Results: Data on the disease-specific costs for 253 patients in 2020 were analyzed. The mean total costs were calculated at €5551 (±€5805, median = €2611, range = €274–€21 667) per 3 months, comprising mean direct costs of €1861 (±€1905, median = €1276, range = €327–€13 158) and mean indirect costs of €3690 (±€5298, median = €0, range = €0–€11 925). The main direct cost components were hospitalization (42.4%), antiseizure medication (42.2%), and outpatient care (6.2%). Productivity losses due to early retirement (53.6%), part-time work or unemployment (30.8%), and seizure-related off-days (15.6%) were the main reasons for indirect costs. However, compared to 2013, there was no significant increase of direct costs (−10.0%), and indirect costs significantly increased (p < .028, +35.1%), resulting in a significant increase in total epilepsy-related costs (p < .047, +20.2%). Compared to the 2013 study population, a significant increase of cost of illness could be observed (p = .047).
Significance: The present study shows that disease-related costs in adult patients with active epilepsy increased from 2013 to 2020. As direct costs have remained constant, this increase is attributable to an increase in indirect costs. These findings highlight the impact of productivity loss caused by early retirement, unemployment, working time reduction, and seizure-related days off.
Background: Atypical EGFR mutations occur in 10%-30% of non-small-cell lung cancer (NSCLC) patients with EGFR mutations and their sensitivity to classical epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) is highly heterogeneous. Patients harboring one group of uncommon, recurrent EGFR mutations (G719X, S768I, L861Q) respond to EGFR-TKI. Exon 20 insertions are mostly insensitive to EGFR-TKI but display sensitivity to exon 20 inhibitors. Clinical outcome data of patients with very rare point and compound mutations upon systemic treatments are still sparse to date.
Patients and methods: In this retrospective, multicenter study of the national Network Genomic Medicine (nNGM) in Germany, 856 NSCLC cases with atypical EGFR mutations including co-occurring mutations were reported from 12 centers. Clinical follow-up data after treatment with different EGFR-TKIs, chemotherapy and immune checkpoint inhibitors were available from 260 patients. Response to treatment was analyzed in three major groups: (i) uncommon mutations (G719X, S7681, L861Q and combinations), (ii) exon 20 insertions and (iii) very rare EGFR mutations (very rare single point mutations, compound mutations, exon 18 deletions, exon 19 insertions).
Results: Our study comprises the largest thus far reported real-world cohort of very rare EGFR single point and compound mutations treated with different systemic treatments. We validated higher efficacy of EGFR-TKI in comparison to chemotherapy in group 1 (uncommon), while most exon 20 insertions (group 2) were not EGFR-TKI responsive. In addition, we found TKI sensitivity of very rare point mutations (group 3) and of complex EGFR mutations containing exon 19 deletions or L858R mutations independent of the combination partner. Notably, treatment responses in group 3 (very rare) were highly heterogeneous. Co-occurring TP53 mutations exerted a non-significant trend for a detrimental effect on outcome in EGFR-TKI-treated patients in groups 2 and 3 but not in group 1.
Conclusions: Based on our findings, we propose a novel nNGM classification of atypical EGFR mutations.
Purpose: Total elbow arthroplasty (TEA) has evolved over the last years, with satisfactory early results, mainly not only in degenerative arthritis, but also increasingly after trauma. Outcome studies in recently published papers are mainly based on the range of motion (ROM), complication rate as well as patient-reported outcome scales and questionnaires. The purpose of this study was to add a new perspective with the “Purdue Pegboard” skill tests in a homogenous set of elderly trauma patients to contribute to a more precise objective outcome measurement in this specific population.
Methods: A retrospective review was performed on a consecutive cohort of all patients with age above 60 years that received TEA after trauma. Data from follow-up examinations over a standardized time-schedule within 2 years after TEA were included. Mayo Elbow Performance Score (MEPS), “Disability of Arm, Shoulder and Hand” (DASH) Questionnaire, ROM as well as test-scores using the Pegboard test were evaluated.
Results: Mean age was 76.0 years ± 10.3. Indications for TEA were posttraumatic arthrosis in 68.8% (n = 11) and extensive fractures that could not be reconstructed surgically in 31.3% (n = 5). The mean score of MEPS was 82.81 ± 16.63 and 29.18 ± 12.01 in the DASH. ROM presented with a mean of 109.7° ± 15.4. Patients demonstrated good, but marginally reduced test scores in the Pegboard skill tests in comparison with the healthy reference population. No relevant differences between the arm with and the arm without TEA (0.3 ± 3.6; p = 0.715) were noted after 2 years.
Conclusion: In the elderly trauma patient with complex fractures of the elbow, TEA is a good alternative to joint reconstruction using various osteosynthesis techniques. TEA is able to avoid revision surgery after open reduction and internal fixation of complex fractures. In cases of failed reconstruction, it is also a viable secondary procedure in posttraumatic arthrosis. Good outcomes in functionality and dexterity can be achieved. Skill tests like the Purdue Pegboard could add a valuable perspective in assessing functional outcomes after TEA.
Highlights
• Consider tissue expanders for challenging DBS cases in PD patients with hardware erosion.
• Placement of tissue expander is essential in planning the reconstruction.
• MRI-compatibility of the tissue expander is paramount for shortening the total duration of anesthesia.
• Role of routine skin biopsies to identify PD patients at additional risk for developing scalp defects should be investigated.
Tinnitus is a symptom experienced by most people at least once in their lifetime. In most documented cases, a new onset of chronic tinnitus can be chronologically correlated with hearing loss. However, tinnitus can also occur in people with (apparently) normal hearing and remains without a traceable preceding cause. Despite the frequency of occurrence of tinnitus, the pathophysiological mechanisms are still not fully understood. A currently proposed hypothesis focuses on a "hidden" hearing loss called synaptopathy as a pathomechanism of tinnitus in normal hearing subjects. In the present study, the objective was to test whether finestructure audiometry or measurement of otoacoustic emissions can reveal possibly overlooked hearing impairment in presumed normalhearing individuals with chronic tinnitus. Thus, a hearing loss not audiologically detectable by the usual methods would supplement or replace the presumed synaptopathic pathomechanism. Another objective was to attempt to replicate the existing findings of another research group on synaptopathy as cause for tinnitus in normal hearing people. Schaette and McAlpine (2011) were able to demonstrate a significant difference in wave I amplitudes between groups of normal hearing subjects with and without chronic tinnitus by deriving clickevoked auditory brainstem potentials, thus supporting the hypothesis of synaptopathy18.
For the present study, a cohort of normal-hearing subjects consisting of a group of tinnitus subjects (N = 15) and a control group (N = 14) was tested. Manual puretone audiometry with 11 test frequencies was conducted to determine hearing performance. Inclusion criteria were defined as air conducted hearing thresholds of 10 dB HL or lower. A deviation at a test frequency of 15 dB HL or less was tolerated. Data of tinnitus characteristics, such as pitch and intensity, were collected by presentation and matching of comparative tones, quality and subjective disturbance by questionnaire. Furthermore, data was obtained from both test groups by Békésy gliding frequency audiometry (794 test frequencies), as well as DPOAE measurement (36 test frequencies) and auditory brainstem response (ABR) audiometry (derivation of early auditory evoked potentials). The results showed a correlation of the determined tinnitus comparison pitch with the frequency location of the largest deviation (impairment) from the normal hearing curve in the Békésy gliding frequency audiometry (p = 0.032). All further analyses of the finestructure hearing curve (steepness of hearing loss, slope, number of hearing loss dips) showed no statistically significant relationship between the morphology of the fine-structure hearing curve and tinnitus characteristics. Finestructure measurement revealed areas of hearing loss that were not mapped in manual puretone audiometry. These "undetected" hearing losses would have led to the exclusion of 12 of 29 subjects (41.4 %) if the finestructure hearing curve had been used as an inclusion criterion. A direct comparison of the mean finestructure hearing curves of both test groups showed a statistically significant better mean hearing performance of the tinnitus group (p < 0.05) in 3 different test frequency ranges (1.5 kHz, 3 kHz, 7 kHz) with a maximum of 4 dB HL. Analy-sis of the mean amplitudes of wave I of the ABRs showed, contrary to expectation, a weak trend toward higher amplitudes in the tinnitus group (p = 0.06). According to Schaette and McAlpine (2011), synaptopathy pathogenesis should have resulted in an opposite trend, i.e., a decrease in wave I amplitude in the tinnitus group. As a secondary finding, a weak trend between wave I amplitude and subjectively perceived disturbance of tinnitus was demonstrated (p = 0.06). Statistical analysis of the parameters determined from the DPOAE measurements did not reveal any significant differences between the tinnitus group and control group. Direct comparison of the DPOAE and finestructure hearing curves, revealed a significant difference in the differences of the frequencyspecific measurements around 2.4 kHz (p = 0.007).
The results of the study suggest that in previous studies with supposedly normal hearing tinnitus subjects there were unrecognized hearing losses that either went unrecognized by the screening by manual puretone audiometry, or subjects with previously aboveaverage hearing experienced a subtle spontaneous decrease in their hearing as tinnitus pathogenesis. This assumption is also supported by the fact that there is a significant correlation between the frequency range of the greatest hearing loss in the finestructure hearing curves and the tinnitus frequency.
The suspected pathomechanism of synaptopathy in "normal hearing" subjects with tinnitus could not be confirmed. The correlation between wave I amplitudes and subjectively perceived disturbance by tinnitus, indicated by the data of this study, should be investigated in more detail in future studies. Further research with more accurate measurement methods and larger subject groups is needed to clarify the hypothesis "Genesis of chronic subjective tinnitus without hearing loss".
Background: Glioblastoma (GBM) patients are at particularly high risk for thrombotic complications. In the event of a postoperative pulmonary embolism, therapeutic anticoagulation (tAC) is indispensable. The impact of therapeutic anticoagulation on recurrence pattern in GBM is currently unknown. Methods: We conducted a matched-pair cohort analysis of 57 GBM patients with or without tAC that were matched for age, sex, gross total resection and MGMT methylation status in a ratio of 1:2. Patients’ characteristics and clinical course were evaluated using medical charts. MRI characteristics were evaluated by two independent authors blinded to the AC status. Results: The morphologic MRI appearance in first GBM recurrence showed a significantly higher presence of multifocal, midline crossing and sharp demarcated GBM recurrence patterns in patients with therapeutic tAC compared to the matched control group. Although statistically non-significant, the therapeutic tAC cohort showed increased survival. Conclusion: Therapeutic anticoagulation induced significant morphologic changes in GBM recurrences. The underlying pathophysiology is discussed in this article but remains to be further elucidated.
Acinetobacter baumannii can thrive on a broad range of substrates such as sugars, alcohols, lipids, amino acids and aromatic compounds. The latter three are abundant in the human host and are potential candidates as carbon sources for the metabolic adaptation of A. baumannii to the human host. In this study we determined the biodegradative activities of A. baumannii AYE with monocyclic aromatic compounds. Deletion of genes encoding the key enzymes of the ß-ketoadipate pathway, the protocatechuate-3,4-dioxygenase (ΔpcaHG) and the catechol-1,2-dioxygenase (ΔcatA), led to a complete loss of growth on benzoate and p-hydroxybenzoate, suggesting that these substrates are metabolized via the two distinct branches (pca and cat) of this pathway. Furthermore, we investigated the potential role of these gene products in host adaptation by analyzing the capability of the mutants to resist complement-mediated killing. These studies revealed that the mutants exhibit a decreased complement resistance, but a dramatic increase in survival in normal human serum in the presence of p-hydroxybenzoate or protocatechuate. These results indicate that the ß-ketoadipate pathway plays a role in adaptation of A. baumannii to the human host. Moreover, the single and double mutants exhibited increased antibiotic resistances indicating a link between the two dioxygenases and antibiotic resistance.
Highlights
• Overview on functional work performed in rodent, zebrafish and fruit fly models of ADHD and its comorbidities.
• Comprehensive search for new genetically modified mouse models to study ADHD-related and comorbid traits.
• Review of behavioral assays available in animal models to test ADHD-related and comorbid traits.
• Animal models to assess environmental effects contributing to the epigenetic mechanisms of ADHD and comorbidities.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder resulting from the interaction between genetic and environmental risk factors. It is well known that ADHD co-occurs frequently with other psychiatric disorders due, in part, to shared genetics factors. Although many studies have contributed to delineate the genetic landscape of psychiatric disorders, their specific molecular underpinnings are still not fully understood. The use of animal models can help us to understand the role of specific genes and environmental stimuli-induced epigenetic modifications in the pathogenesis of ADHD and its comorbidities. The aim of this review is to provide an overview on the functional work performed in rodents, zebrafish and fruit fly and highlight the generated insights into the biology of ADHD, with a special focus on genetics and epigenetics. We also describe the behavioral tests that are available to study ADHD-relevant phenotypes and comorbid traits in these models. Furthermore, we have searched for new models to study ADHD and its comorbidities, which can be useful to test potential pharmacological treatments.
Inguinal hernia repair (IHR) is a common procedure in childhood. Laparoscopic IHR has been evolving for the last three decades. Although clear advantages have been shown, adaptation in Germany has been slow. We aim to study the current status of pediatric laparoscopic IHR. A survey was sent to all 89 pediatric surgical departments in Germany on current practices and preferences of open versus laparoscopic IHR. Two nationwide databases of administrative claims data from 2019 were analyzed and correlated with responses from the survey. A total of 56% of the pediatric surgical departments supplied data through the quality reports. The recall of our survey was 58% of all pediatric surgery departments. According to the pooled data, laparoscopic IHR was performed in 8.2% of all inpatients treated. Laparoscopic IHR was considered a training procedure in 48% of the departments. Five different laparoscopic techniques were described (most commonly percutaneous closure of the hernia under laparoscopic vision). The choice between open and laparoscopic IHR was mainly determined by the child’s age. Currently, only a minority of German children undergo inguinal hernia repair by laparoscopy. More training opportunities in the form of hands-on and video workshops may lead to more widespread employment of the laparoscopic technique.
Vascular integrity is essential for organ homeostasis to prevent edema formation and infiltration of inflammatory cells. Long non-coding RNAs (lncRNAs) are important regulators of gene expression and often expressed in a cell type-specific manner. By screening for endothelial-enriched lncRNAs, we identified the undescribed lncRNA NTRAS to control endothelial cell functions. Silencing of NTRAS induces endothelial cell dysfunction in vitro and increases vascular permeability and lethality in mice. Biochemical analysis revealed that NTRAS, through its CA-dinucleotide repeat motif, sequesters the splicing regulator hnRNPL to control alternative splicing of tight junction protein 1 (TJP1; also named zona occludens 1, ZO-1) pre-mRNA. Deletion of the hnRNPL binding motif in mice (Ntras∆CA/∆CA) significantly repressed TJP1 exon 20 usage, favoring expression of the TJP1α- isoform, which augments permeability of the endothelial monolayer. Ntras∆CA/∆CA mice further showed reduced retinal vessel growth and increased vascular permeability and myocarditis. In summary, this study demonstrates that NTRAS is an essential gatekeeper of vascular integrity.
The aim of this study is to investigate the incidental prostate cancer (iPCa) detection rates of different embedding methods in a large, contemporary cohort of patients with bladder outlet obstruction (BOO) treated with transurethral surgery. We relied on an institutional tertiary-care database to identify BOO patients who underwent either transurethral loop resection or laser (Holmium:yttrium–aluminium garnet) enucleation of the prostate (HoLEP) between 01/2012 and 12/2019. Embedding methods differed with regard to the extent of the additional prostate tissue submitted following the first ten cassettes of primary embedding (cohort A: one [additional] cassette/10 g residual tissue vs. cohort B: complete embedding of the residual tissue). Detection rates of iPCa among the different embedding methods were compared. Subsequently, subgroup analyses by embedding protocol were repeated in HoLEP-treated patients only. In the overall cohort, the iPCa detection rate was 11% (46/420). In cohort A (n = 299), tissue embedding resulted in a median of 8 cassettes/patient (range 1–38) vs. a median of 15 (range 2–74) in cohort B (n = 121) (p < .001). The iPCa detection rate was 8% (23/299) and 19% (23/121) in cohort A vs. cohort B, respectively (p < .001). Virtual reduction of the number of tissue cassettes to ten cassettes resulted in a iPCa detection rate of 96% in both cohorts, missing one stage T1a/ISUP grade 1 carcinoma. Increasing the number of cassettes by two and eight cassettes, respectively, resulted in a detection rate of 100% in both cohorts without revealing high-grade carcinomas. Subgroup analyses in HoLEP patients confirmed these findings, demonstrated by a 100 vs. 96% iPCa detection rate following examination of the first ten cassettes, missing one case of T1a/ISUP 1. Examination of 8 additional cassettes resulted in a 100% detection rate. The extent of embedding of material obtained from transurethral prostate resection correlates with the iPCa detection rate. However, the submission of 10 cassettes appears to be a reasonable threshold to reduce resource utilization while maintaining secure cancer detection.
Background: Routine human papillomavirus (HPV) testing is performed in cervival cancer and is required for classification of some head and neck cancers. In penile cancer a statement on HPV association of the carcinoma is required. In most cases p16 immunohistochemistry as a surrogate marker is applied in this setting. Since differing clinical outcomes for HPV positive and HPV negative tumors are described we await HPV testing to be requested more frequently by clinicians, also in the context of HPV vaccination, where other HPV subtypes are expected to emerge.
Method: Therefore, a cohort of archived, formalin-fixed paraffin embedded (FFPE) penile neoplasias was stained for p16 and thereafter tested for HPV infection status via PCR based methods. Additionally to Sanger sequencing, we chose LCD-Array technique (HPV 3.5 LCD-Array Kit, Chipron; LCD-Array) for the detection of HPV in our probes expecting a less time consuming and sensitive HPV test for our probes.
Results: We found that LCD-Array is a sensitive and feasible method for HPV testing in routine diagnostics applicable to FFPE material in our cohort. Our cohort of penile carcinomas and carcinomas in situ was associated with HPV infection in 61% of cases. We detected no significant association between HPV infection status and histomorphological tumor characteristics as well as overall survival.
Conclusions: We showed usability of molecular HPV testing on a cohort of archived penile carcinomas. To the best of our knowledge, this is the first study investigating LCD-Array technique on a cohort of penile neoplasias.
Cardiovascular disease (CVD) is the leading cause of death in the western world. Aging as the major risk factor for the development of CVD leads to structural changes in the heart and the vasculature. In addition to endothelial cells, mural cells, including smooth muscle cells and pericytes, form the vascular wall. Pericytes are defined as the perivascular cells located in the basement membrane of the capillaries, which are the smallest components of the vascular system and ensure the gas exchange in the tissue. In the different parts of the terminal vascular bed, pericytes receive different phenotypes and organ-specific functions. In addition to the stabilization of the vascular wall, pericytes are relevant for the formation of new vessels. Due to their potential of multipotent stem cells, pericytes can differentiate into different cell types and thus take a position in developmental processes. Pericytes play a crucial role in the development and diseases of the vascular system. Moreover, pericyte coverage is reduced in the aged heart. Nonetheless, the function of pericytes in the heart and their importance during cardiac aging is not completely understood.
To study the pericyte population in the aging heart, we have performed single-nucleus RNA-sequencing analysis comparing hearts from 12-weeks-old (young) and 18-month-old (old) mice. The detailed analysis of 336 differentially expressed genes (DEG) revealed that Rgs5 is downregulated in aged pericytes. Regulator of G-protein signaling 5 (RGS5), an established marker for pericytes, is involved the regulation of the blood pressure and in the formation of various cardiovascular diesases, including cardiac hypertrophy, myocardial infarction and atherosclerosis. We have furthermore confirmed this observation in vivo. Gene ontology (GO) analysis of DEG revealed that aged pericytes are characterized by the downregulation of genes involved in cell adhesion. Further, we have performed cell biology approaches using human brain vascular pericytes (hBVP) to investigate the role of Rgs5 in pericytes in vitro. Efficient knockdown of RGS5, although has no effect on cellular metabolism, viability and endothelial permeability, induces a reduction of pericyte adhesion to both a gelatine matrix and endothelial cells in a 3D matrigel culture. This was associated with the formation of filopodia. The altered phenotype suggested a changing identity of the pericytes. We could confirm that a loss of RGS5 causes a decreased expression of the pericyte markers PDGFRb and NOTCH3 and also leads to an overexpression of COL1A1, a fibroblast marker.
Together, our findings suggest that RGS5 is required for pericyte adhesion to endothelial cells and its downregulation in the aged mural cells could explain the reduction of pericyte coverage in the aged hearts. Further, RGS5 may be the key regulator for pericyte identity, as pericytes show an altered expression profile of cellular markers. The dedifferentiation of pericytes to a more fibroblast-like cell type could explain the increased fibrosis during age-related cardiac remodeling. We believe that RGS5 is a great candidate to explore and study the molecular mechanisms that regulate pericyte function in the heart, both in homeostasis and during aging.
Rationale and objectives: The objective of this study was to analyze the role of dynamic magnetic resonance imaging (MRI) in patients who suffered from groin pain and whose physical examination and ultrasound returned inconclusive/indefinite results, as well as in patients receiving an ongoing assessment for a previous herniotomy.
Material and methods: For this study, 25 patients 14 women and 11 men were selected with a mean age of 41.6 years, including clinical complaints, such as groin pain and or a previous herniotomies. These patients underwent dynamic MRI. Reports were created by a radiology resident and a radiology consultant. Clinical and ultrasound documentation were compared to with imaging results from the MRI.
Results: The results of the dynamic MRI were negative for 23 patients (92%) and positive for two patients (8%). One patient suffered from an indirect hernia and one from a femoral hernia. A repeated hernia was an excluding for the preoperated patients with pain and ongoing assessment.
Conclusions: Dynamic MRI shows substantially higher diagnostic performance in exclusion of inguinal hernia, when compared to a physical examination and ultrasound. The examination can also be used in assessments to analyze the operation’s results.
(1) AlphαSynuclein (αSyn) is a synaptic protein which is expressed in the nervous system and has been linked to neurodegenerative diseases, in particular Parkinson’s disease (PD). Symptoms of PD are mainly due to overexpression and aggregation of αSyn and include pain. However, the interconnection of αSyn and pain has not been clarified so far. (2) We investigated the potential effects of a αSyn knock-out on the nociceptive behaviour in mouse models of acute, inflammatory and neuropathic pain. Furthermore, we assessed the impact of αSyn deletion on pain-related cellular and molecular mechanisms in the spinal cord in these models. (3) Our results showed a reduction of acute cold nociception in αSyn knock-out mice while responses to acute heat and mechanical noxious stimulation were similar in wild type and knock-out mice. Inflammatory nociception was not affected by αSyn knock-out which is also mirrored by unaltered inflammatory gene expression. In contrast, in the SNI model of neuropathic pain, αSyn knock-out mice showed decreased mechanical allodynia as compared to wild type mice. This effect was associated with reduced proinflammatory mechanisms and suppressed activation of MAP kinase signalling in the spinal cord while endogenous antinociceptive mechanisms are not inhibited. (4) Our data indicate that αSyn plays a role in neuropathy and its inhibition might be useful to ameliorate pain symptoms after nerve injury.
Background: The extramuscular connective tissue (ECT) has been shown to play a significant role in mechanical force transmission between musculoskeletal structures. Due to this and owing to its tight connection with the underlying muscle, the ECT may be vulnerable to excessive loading. The present study aimed to investigate the effect of eccentric elbow flexor exercise on the morphology of the biceps brachii ECT. In view of the high nociceptive capacity of the ECT, an additional objective was to elucidate the potential relationship between ECT damage and the occurrence of delayed onset muscle soreness (DOMS).
Methods: Eleven healthy participants (♂ = 7; 24 ± 2 years) performed fatiguing dumbbell elbow flexor eccentric exercise (EE) for one arm and concentric exercise (CE) for the other arm in random order and with random arm allocation. Before, immediately after and 24–96 h post-exercise, maximal voluntary isometric contraction torque of the elbow flexors (dynamometer), pressure pain (algometer), palpation pain (100 mm visual analog scale), biceps brachii ECT thickness and ECT/muscle mobility during passive movement (both high-resolution ultrasound) were examined.
Results: Palpation pain, suggestive of DOMS, was greater after EE than CE, and maximal voluntary isometric contraction torque decreased greater after EE than CE (p < .05). Relative to CE, EE increased ECT thickness at 48 (+ 17%), 72 (+ 14%) and 96 (+ 15%) hours post-exercise (p < .05). At 96 h post-EE, the increase in ECT thickness correlated with palpation pain (r = .68; p < .05). ECT mobility was not different between conditions, but compared to CE, muscle displacement increased at 24 (+ 31%), 72 (+ 31%) and 96 (+ 41%) hours post-EE (p < .05).
Conclusion: Collectively, these results suggest an involvement of the ECT changes in delayed onset muscle soreness.
Renal glomerular diseases such as glomerulosclerosis and diabetic nephropathy often result in the loss of glomerular function and consequently end-stage renal disease. The glomerulus consists of endothelial cells, mesangial cells and glomerular epithelial cells also referred to as podocytes. A fine-tuned crosstalk between glomerular cells warrants control of growth factor synthesis and of matrix production and degradation, preserving glomerular structure and function. Hydrogen sulfide (H2S) belongs together with nitric oxide (NO) and carbon monoxide (CO) to the group of gasotransmitters. During the last three decades, these higher concentration toxic gases have been found to be produced in mammalian cells in a well-coordinated manner. Recently, it became evident that H2S and the other gasotransmitters share common targets as signalling devices that trigger mainly protective pathways. In several animal models, H2S has been demonstrated as a protective factor in the context of kidney disorders, in particular of diabetic nephropathy. Here, we focus on the synthesis and action of H2S in glomerular cells, its beneficial effects in the glomerulus and its action in the context of the other gaseous signalling molecules NO and CO.
Conduct Disorder (CD) is an impairing psychiatric disorder of childhood and adolescence characterized by aggressive and dissocial behavior. Environmental factors such as maternal smoking during pregnancy, socio-economic status, trauma, or early life stress are associated with CD. Although the number of females with CD is rising in Western societies, CD is under-researched in female cohorts. We aimed at exploring the epigenetic signature of females with CD and its relation to psychosocial and environmental risk factors. We performed HpaII sensitive genome-wide methylation sequencing of 49 CD girls and 50 matched typically developing controls and linear regression models to identify differentially methylated CpG loci (tags) and regions. Significant tags and regions were mapped to the respective genes and tested for enrichment in pathways and brain developmental processes. Finally, epigenetic signatures were tested as mediators for CD-associated risk factors. We identified a 12% increased methylation 5’ of the neurite modulator SLITRK5 (FDR = 0.0046) in cases within a glucocorticoid receptor binding site. Functionally, methylation positively correlated with gene expression in lymphoblastoid cell lines. At systems-level, genes (uncorr. P < 0.01) were associated with development of neurons, neurite outgrowth or neuronal developmental processes. At gene expression level, the associated gene-networks are activated perinatally and during early childhood in neocortical regions, thalamus and striatum, and expressed in amygdala and hippocampus. Specifically, the epigenetic signatures of the gene network activated in the thalamus during early childhood correlated with the effect of parental education on CD status possibly mediating its protective effect. The differential methylation patterns identified in females with CD are likely to affect genes that are expressed in brain regions previously indicated in CD. We provide suggestive evidence that protective effects are likely mediated by epigenetic mechanisms impairing specific brain developmental networks and therefore exerting a long-term effect on neural functions in CD. Our results are exploratory and thus, further replication is needed.
After myocardial infarction in the adult heart the remaining, non-infarcted tissue adapts to compensate the loss of functional tissue. This adaptation requires changes in gene expression networks, which are mostly controlled by transcription regulating proteins. Long non-coding transcripts (lncRNAs) are now recognized for taking part in fine-tuning such gene programs. We identified and characterized the cardiomyocyte specific lncRNA Sweetheart RNA (Swhtr), an approximately 10 kb long transcript divergently expressed from the cardiac core transcription factor coding gene Nkx2-5. We show that Swhtr is dispensable for normal heart development and function, but becomes essential for the tissue adaptation process after myocardial infarction. Re-expressing Swhtr from an exogenous locus rescues the Swhtr null phenotype. Genes depending on Swhtr after cardiac stress are significantly occupied, and therefore most likely regulated by NKX2-5. Our results indicate a synergistic role for Swhtr and the developmentally essential transcription factor NKX2-5 in tissue adaptation after myocardial injury.
The Masquelet technique is used to treat large bone defects; it is a two-stage procedure based on an induced membrane. To improve the induced membrane process, demineralized bone matrix in granular (GDBM) and fibrous form (f-DBM) was tested with and without bone marrow mononuclear cells (BMC) as filling of the membrane against the gold standard filling with syngeneic cancellous bone (SCB). A total of 65 male Sprague–Dawley rats obtained a 5 mm femoral defect. These defects were treated with the induced membrane technique and filled with SCB, GDBM, or f-DBM, with or without BMC. After a healing period of eight weeks, the femurs were harvested and submitted for histological, radiological, and biomechanical analyses. The fracture load in the defect zone was lower compared to SCB in all groups. However, histological analysis showed comparable new bone formation, bone mineral density, and cartilage proportions and vascularization. The results suggest that f-DBM in combination with BMC and the induced membrane technique cannot reproduce the very good results of this material in large, non-membrane coated bone defects, nevertheless it supports the maturation of new bone tissue locally. It can be concluded that BMC should be applied in lower doses and inflammatory cells should be removed from the cell preparation before implantation.
Background: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery.
Method: In this single-centre observational study, patients ≥ 65 years undergoing major surgery were screened for anaemia and ID. Patients were assigned to the following groups: A− (no anaemia); A−,ID+,T+ (no anaemia, iron-deficient, intravenous iron supplementation); A+ (anaemia); and A+,ID+,T+ (anaemia, iron-deficient, intravenous iron supplementation).
Results: Of 4,381 patients screened at the anaemia walk-in clinic, 2,381 (54%) patients were ≥ 65 years old and 2,191 cases were included in analysis. The ID prevalence was 63% in patients with haemoglobin (Hb) < 8 g/dl, 47.2% in patients with Hb from 8.0 to 8.9 g/dl, and 44.3% in patients with Hb from 9 to 9.9 g/dl. In severely anaemic patients, an Hb increase of 0.6 (0.4; 1.2) and 1.2 (0.7; 1.6) g/dl was detected with iron supplementation 6–10 and > 10 days before surgery, respectively. Hb increased by 0 (-0.1; 0) g/dl with iron supplementation 1–5 days before surgery, 0.2 (-0.1; 0.5) g/dl with iron supplementation 6–10 days before surgery, and 0.2 (-0.2; 1.1) g/dl with supplementation > 10 days before surgery (p < 0.001 for 1–5 vs. 6–10 days). Overall, 58% of A+,ID+,T+ patients showed an Hb increase of > 0.5 g/dl. The number of transfused red blood cell units was significantly lower in patients supplemented with iron (0 (0; 3)) compared to non-treated anaemic patients (1 (0; 4)) (p = 0.03). Patients with iron supplementation > 6 days before surgery achieved mobility 2 days earlier than patients with iron supplementation < 6 days.
Conclusions: Intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with ID anaemia.
Besides transcription, RNA decay accounts for a large proportion of regulated gene expression and is paramount for cellular functions. Classical RNA surveillance pathways, like nonsense-mediated decay (NMD), are also implicated in the turnover of non-mutant transcripts. Whereas numerous protein factors have been assigned to distinct RNA decay pathways, the contribution of long non-coding RNAs (lncRNAs) to RNA turnover remains unknown. Here we identify the lncRNA CALA as a potent regulator of RNA turnover in endothelial cells. We demonstrate that CALA forms cytoplasmic ribonucleoprotein complexes with G3BP1 and regulates endothelial cell functions. A detailed characterization of these G3BP1-positive complexes by mass spectrometry identifies UPF1 and numerous other NMD factors having cytoplasmic G3BP1-association that is CALA-dependent. Importantly, CALA silencing impairs degradation of NMD target transcripts, establishing CALA as a non-coding regulator of RNA steady-state levels in the endothelium.
Mechanisms by which specific histone modifications regulate distinct gene regulatory networks remain little understood. We investigated how H3K79me2, a modification catalyzed by DOT1L and previously considered a general transcriptional activation mark, regulates gene expression in mammalian cardiogenesis. Early embryonic cardiomyocyte ablation of Dot1l revealed that H3K79me2 does not act as a general transcriptional activator, but rather regulates highly specific gene regulatory networks at two critical cardiogenic junctures: left ventricle patterning and postnatal cardiomyocyte cell cycle withdrawal. Mechanistic analyses revealed that H3K79me2 in two distinct domains, gene bodies and regulatory elements, synergized to promote expression of genes activated by DOT1L. Surprisingly, these analyses also revealed that H3K79me2 in specific regulatory elements contributed to silencing genes usually not expressed in cardiomyocytes. As DOT1L mutants had increased numbers of postnatal mononuclear cardiomyocytes and prolonged cardiomyocyte cell cycle activity, controlled inhibition of DOT1L might be a strategy to promote cardiac regeneration post-injury.
Long non-coding RNAs (lncRNAs) can act as regulatory RNAs which, by altering the expression of target genes, impact on the cellular phenotype and cardiovascular disease development. Endothelial lncRNAs and their vascular functions are largely undefined. Deep RNA-Seq and FANTOM5 CAGE analysis revealed the lncRNA LINC00607 to be highly enriched in human endothelial cells. LINC00607 was induced in response to hypoxia, arteriosclerosis regression in non-human primates and also in response to propranolol used to induce regression of human arteriovenous malformations. siRNA knockdown or CRISPR/Cas9 knockout of LINC00607 attenuated VEGF-A-induced angiogenic sprouting. LINC00607 knockout in endothelial cells also integrated less into newly formed vascular networks in an in vivo assay in SCID mice. Overexpression of LINC00607 in CRISPR knockout cells restored normal endothelial function. RNA- and ATAC-Seq after LINC00607 knockout revealed changes in the transcription of endothelial gene sets linked to the endothelial phenotype and in chromatin accessibility around ERG-binding sites. Mechanistically, LINC00607 interacted with the SWI/SNF chromatin remodeling protein BRG1. CRISPR/Cas9-mediated knockout of BRG1 in HUVEC followed by CUT&RUN revealed that BRG1 is required to secure a stable chromatin state, mainly on ERG-binding sites. In conclusion, LINC00607 is an endothelial-enriched lncRNA that maintains ERG target gene transcription by interacting with the chromatin remodeler BRG1.